{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":145,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":145,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"89014c6b0aca","filters":{"venue":"Regular and Young Investigator Award Abstracts"}},"results":[{"id":"W4308399396","doi":"10.1136/jitc-2022-sitc2022.0558","title":"558 CTX130 allogeneic CRISPR-Cas9–engineered chimeric antigen receptor (CAR) T cells in patients with advanced clear cell renal cell carcinoma: Results from the phase 1 COBALT-RCC study","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Renal cell carcinoma; Fludarabine; Medicine; Clear cell renal cell carcinoma; Internal medicine; Refractory (planetary science); Chimeric antigen receptor; Oncology; Gastroenterology; Cyclophosphamide; Cancer research; Immunotherapy; Chemotherapy; Cancer; Biology","authors":[{"name":"Sumanta Pal","is_ca":false},{"name":"Ben Tran","is_ca":false},{"name":"John Haanen","is_ca":false},{"name":"Michael E. Hurwitz","is_ca":false},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Neeraj Agarwal","is_ca":false},{"name":"Nizar Tannir","is_ca":false},{"name":"Elizabeth Budde","is_ca":false},{"name":"Simon J. Harrison","is_ca":false},{"name":"Sebastian Klobuch","is_ca":false},{"name":"Sagar S. Patel","is_ca":false},{"name":"Mary Lee Dequeant","is_ca":false},{"name":"Verena Karsten","is_ca":false},{"name":"Kaitlyn Cohen","is_ca":false},{"name":"Ellen B. Gurary","is_ca":false},{"name":"Henia Dar","is_ca":false},{"name":"Anna Ma","is_ca":false},{"name":"A. Sharma","is_ca":false},{"name":"Samer A. Srour","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01358275220468149,"gpt":0.2454665609501217,"spread":0.2318838087454402,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009349402,0.0005333969,0.0007176059,0.0002244465,0.0004078227,0.00008895021,0.0004537521,0.0001341786,0.0002700058],"category_scores_gemma":[0.0001385236,0.0004197007,0.0001391992,0.0007407345,0.0002822953,0.0001600574,0.000246929,0.001097583,0.00002664449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003071182,"about_ca_system_score_gemma":0.0005493125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001340551,"about_ca_topic_score_gemma":0.00008317419,"domain_scores_codex":[0.9953815,0.0004752024,0.0008385031,0.001071632,0.001405224,0.0008279389],"domain_scores_gemma":[0.9974027,0.0002005135,0.0003199971,0.00111413,0.0001668693,0.000795816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01093347,0.004245551,0.1321316,0.00009595619,0.0002380181,0.0004615535,0.006407877,0.002061876,0.8343323,0.00000152465,0.007815538,0.001274739],"study_design_scores_gemma":[0.04791901,0.008442093,0.6575248,0.0000943995,0.0002792479,0.00002184947,0.004178441,0.0002824638,0.2592193,0.0000148038,0.0210967,0.0009269435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948153,0.000734407,0.000002793234,0.0003903091,0.000374313,0.002635236,0.0006467216,0.00008284593,0.000318074],"genre_scores_gemma":[0.9971241,0.00007966896,0.0004504296,0.0003132138,0.0001818991,0.0001128095,0.000656009,0.0001351318,0.000946755],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5751131,"threshold_uncertainty_score":0.9998255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3104819140","doi":"10.1136/jitc-2020-sitc2020.0428","title":"428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Vismodegib; Internal medicine; Clinical endpoint; Interim analysis; Basal cell carcinoma; Progression-free survival; Oncology; Surgery; Gastroenterology; Randomized controlled trial; Chemotherapy; Adverse effect; Basal cell","authors":[{"name":"Karl D. Lewis","is_ca":false},{"name":"Ketty Peris","is_ca":false},{"name":"Aleksandar Sekulić","is_ca":false},{"name":"Alexander Stratigos","is_ca":false},{"name":"Lara Dunn","is_ca":false},{"name":"Zeynep Eroglu","is_ca":false},{"name":"Anne Lynn S. Chang","is_ca":false},{"name":"Michael R. Migden","is_ca":false},{"name":"Siyu Li","is_ca":false},{"name":"Kosalai Kal Mohan","is_ca":false},{"name":"Ebony Coates","is_ca":false},{"name":"Emmanuel Chiebuka Okoye","is_ca":false},{"name":"Jean‐François Baurain","is_ca":false},{"name":"Oliver Bechter","is_ca":false},{"name":"Axel Hauschild","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Leonel F. Hernandez‐Aya","is_ca":false},{"name":"Lisa Licitra","is_ca":false},{"name":"Rogerio I. Neves","is_ca":false},{"name":"E.P. Yanez Ruiz","is_ca":false},{"name":"Frank Seebach","is_ca":false},{"name":"David M. Weinreich","is_ca":false},{"name":"George D. Yancopoulos","is_ca":false},{"name":"Israel Lowy","is_ca":false},{"name":"Timothy G. Bowler","is_ca":false},{"name":"Matthew G. Fury","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02856484540316573,"gpt":0.270789013981223,"spread":0.2422241685780573,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002589799,0.000340135,0.0006605349,0.0002077749,0.0000710785,0.00003675068,0.0001749694,0.0001122542,0.000001300236],"category_scores_gemma":[0.0007331726,0.000266149,0.0001345962,0.0005152943,0.0001731042,0.00001209019,0.00009176711,0.0001218816,0.000001185681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003229282,"about_ca_system_score_gemma":0.0001735328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002956717,"about_ca_topic_score_gemma":0.00008719794,"domain_scores_codex":[0.9979314,0.00007707924,0.0006454673,0.0007064319,0.0002849085,0.0003547381],"domain_scores_gemma":[0.9986241,0.00004601654,0.0003333448,0.0003253949,0.0002155774,0.0004555464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.03979018,0.003933584,0.2824783,0.002765852,0.003646856,0.0002199197,0.01297251,0.01064834,0.628253,0.00002269762,0.01302107,0.002247635],"study_design_scores_gemma":[0.01102948,0.00786678,0.1357712,0.0003307151,0.0007527742,0.00000104222,0.0007115796,0.0008667976,0.8401536,0.000006696702,0.001844644,0.0006647296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978448,0.0001474913,0.0001015057,0.0005085811,0.00006380789,0.0008143836,0.0004676517,0.00001327634,0.00003849393],"genre_scores_gemma":[0.9978396,0.000006512205,0.001082881,0.0005362239,0.00006730432,0.00007272125,0.0003164341,0.00004002002,0.00003829677],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2119005,"threshold_uncertainty_score":0.9999791,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3100538981","doi":"10.1136/jitc-2020-sitc2020.0379","title":"379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD8; Medicine; T-cell receptor; Internal medicine; Antigen; Cancer; T cell; Gastroenterology; Oncology; Immunology; Immune system","authors":[{"name":"David S. Hong","is_ca":false},{"name":"Jeffrey Clarke","is_ca":false},{"name":"Tanner M. Johanns","is_ca":false},{"name":"Partow Kebriaei","is_ca":false},{"name":"John V. Heymach","is_ca":false},{"name":"Ahmed Galal","is_ca":false},{"name":"Samuel D. Saibil","is_ca":true},{"name":"Adrian G. Sacher","is_ca":true},{"name":"Francine Brophy","is_ca":false},{"name":"Gareth Betts","is_ca":false},{"name":"Natalie Bath","is_ca":false},{"name":"William Spinner","is_ca":false},{"name":"Alex J. Tipping","is_ca":false},{"name":"Jessica Tucci","is_ca":false},{"name":"Raymond Luke","is_ca":false},{"name":"Trupti Trivedi","is_ca":false},{"name":"Quan Lin","is_ca":false},{"name":"Jean‐Marc Navenot","is_ca":false},{"name":"Paula M. Fracasso","is_ca":false},{"name":"Karen Miller","is_ca":false},{"name":"Elliot Norry","is_ca":false},{"name":"Mark E. Dudley","is_ca":false},{"name":"Marcus O. Butler","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05083607555745884,"gpt":0.2917466332077279,"spread":0.240910557650269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001627317,0.0005189734,0.000867628,0.00007318844,0.0004846163,0.0003957403,0.000225641,0.0002088382,0.0001500033],"category_scores_gemma":[0.001210124,0.0003587706,0.00009039772,0.0003097787,0.001035082,0.0003364893,0.0001394323,0.0009105758,0.00001066612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000521771,"about_ca_system_score_gemma":0.00066706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005842632,"about_ca_topic_score_gemma":0.00003859822,"domain_scores_codex":[0.9963791,0.0005882738,0.0006779556,0.0009860826,0.0007941758,0.0005744064],"domain_scores_gemma":[0.9971172,0.0005823215,0.0003449008,0.0004838826,0.0002020696,0.001269629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1053972,0.0007482465,0.03675377,0.0003466146,0.0008368751,0.0003951435,0.008434168,0.0001358993,0.8326491,0.00003510619,0.005593158,0.008674676],"study_design_scores_gemma":[0.3172357,0.01546181,0.1096702,0.001072746,0.001013397,0.0004627105,0.005204679,0.002866653,0.5051961,0.0003610411,0.03841686,0.00303809],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877034,0.001649774,0.00002821818,0.00748589,0.0001339909,0.002383176,0.0002162904,0.0001462076,0.0002530504],"genre_scores_gemma":[0.9901129,0.0006692586,0.005553754,0.0009491079,0.001863468,0.00004592682,0.000591942,0.0001150676,0.00009858899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.327453,"threshold_uncertainty_score":0.9998865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042564","doi":"10.1136/jitc-2023-sitc2023.0695","title":"695 Efficacy and safety of trastuzumab deruxtecan (T-DXd) with durvalumab in patients with non-small cell lung cancer (HER2 altered NSCLC) who progressed on anti-PD1/PD-L1 therapy (HUDSON)","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Durvalumab; Medicine; Internal medicine; Clinical endpoint; Oncology; Tremelimumab; Lung cancer; Trastuzumab; non-small cell lung cancer (NSCLC); Adverse effect; Cancer; Immunotherapy; Clinical trial; Nivolumab; Ipilimumab; Breast cancer","authors":[{"name":"Parneet Cheema","is_ca":true},{"name":"Sylvia Hartl","is_ca":false},{"name":"Marianna Koczywas","is_ca":false},{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Frances A. Shepherd","is_ca":true},{"name":"Quincy S. Chu","is_ca":true},{"name":"Giuseppe Galletti","is_ca":false},{"name":"Mark Gustavson","is_ca":false},{"name":"Sonia Iyer","is_ca":false},{"name":"J. Carl Barrett","is_ca":false},{"name":"Brent Evans","is_ca":false},{"name":"Rakesh Kumar","is_ca":false},{"name":"Jan Cosaert","is_ca":false},{"name":"Keunchil Park","is_ca":false},{"name":"John V. Heymach","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01045595203227388,"gpt":0.2406354814381965,"spread":0.2301795294059226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003597268,0.0004469242,0.0007201844,0.0002513023,0.0001346565,0.00005556164,0.0001280501,0.000185527,0.00001485886],"category_scores_gemma":[0.00002688245,0.0003208558,0.00007515775,0.0005971455,0.0004695054,0.0001347116,0.00002635175,0.0003117032,0.000001388959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001333738,"about_ca_system_score_gemma":0.0005686631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007210397,"about_ca_topic_score_gemma":0.0002225629,"domain_scores_codex":[0.9976698,0.00007751281,0.0005456621,0.0006302589,0.0005376075,0.0005392319],"domain_scores_gemma":[0.9986871,0.00006792337,0.0003086149,0.0004150447,0.0001297238,0.0003915743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0180476,0.0008760779,0.9397039,0.0009931795,0.0006718037,0.00009704966,0.003019642,0.0001742692,0.0153484,0.00000893973,0.0006097518,0.02044935],"study_design_scores_gemma":[0.02229468,0.002102692,0.9470739,0.002245748,0.0001290787,0.00001376865,0.0001628904,0.0001192723,0.0248562,0.0000065252,0.0006016375,0.000393587],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959452,0.001245289,0.000004489465,0.0005324401,0.0001242323,0.001790232,0.00005276755,0.00007650938,0.0002288298],"genre_scores_gemma":[0.9978011,0.001160345,0.0002588654,0.0002766561,0.00007528964,0.00007573388,0.00007664251,0.00008804608,0.0001873288],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02005576,"threshold_uncertainty_score":0.9999244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388084134","doi":"10.1136/jitc-2023-sitc2023.0741","title":"741 TWT-101: a first-in-clinic study of CFI-402411, a hematopoietic progenitor Kinase-1 (HPK1) inhibitor, as single agent or combined with pembrolizumab in subjects with advanced solid malignancies","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University Health Network; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Adverse effect; Gastroenterology; Oncology; Toxicity; Cancer; Immunotherapy","authors":[{"name":"Kyriakos P. Papadopoulos","is_ca":false},{"name":"Scott A. Laurie","is_ca":true},{"name":"Alexander I. Spira","is_ca":false},{"name":"Siqing Fu","is_ca":false},{"name":"Erika Hamilton","is_ca":false},{"name":"Brigette Ma","is_ca":false},{"name":"Judy S. Wang","is_ca":false},{"name":"Manish Sharma","is_ca":false},{"name":"Quincy S. Chu","is_ca":true},{"name":"Anna Spreafico","is_ca":true},{"name":"Mark R. Bray","is_ca":false},{"name":"Dih-Yih Chen","is_ca":false},{"name":"Emily Roberts-Thomson","is_ca":false},{"name":"Roger Sidhu","is_ca":false},{"name":"Omid Hamid","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02282469974766373,"gpt":0.2716791618740001,"spread":0.2488544621263364,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004839745,0.0004659804,0.0009473981,0.000434851,0.0001100058,0.00005603691,0.0001527822,0.0001740917,0.0000241899],"category_scores_gemma":[0.0002201505,0.0003323935,0.00009558148,0.001257473,0.0004273125,0.0001948259,0.00006052286,0.0002938455,0.00001313056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002021519,"about_ca_system_score_gemma":0.0008141621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005618504,"about_ca_topic_score_gemma":0.00411617,"domain_scores_codex":[0.9969741,0.00009552891,0.0008907755,0.0006816132,0.0007198765,0.0006381055],"domain_scores_gemma":[0.9984592,0.0001237062,0.0003491777,0.0005358507,0.0001358193,0.0003962709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1041895,0.01077983,0.523491,0.006363291,0.001586139,0.01431519,0.03509759,0.0004032538,0.2999808,0.00004212102,0.001862515,0.001888803],"study_design_scores_gemma":[0.05087716,0.03043638,0.6716201,0.007364524,0.0004067325,0.001060815,0.01587049,0.00008961055,0.2199949,0.0001257913,0.00102754,0.001125887],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959788,0.0006132535,5.38552e-7,0.0006224492,0.0001917905,0.002280312,0.000009278482,0.0001293077,0.0001742928],"genre_scores_gemma":[0.9983832,0.0001570804,0.000161177,0.0001510096,0.00005990971,0.0002176879,0.00002505381,0.00008547368,0.0007594102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1481291,"threshold_uncertainty_score":0.9999128,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3212914573","doi":"10.1136/jitc-2021-sitc2021.509","title":"509 A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD8; Immunotherapy; Refractory (planetary science); Cytotoxic T cell; Cancer; Internal medicine; Oncology; Cancer immunotherapy; Dosing; Immune system; Cancer research; Immunology; Chemistry; Biology; In vitro","authors":[{"name":"Aung Naing","is_ca":false},{"name":"Margaret K. Callahan","is_ca":false},{"name":"Brian A. Costello","is_ca":false},{"name":"Brendan D. Curti","is_ca":false},{"name":"Evan Hall","is_ca":false},{"name":"Aaron R. Hansen","is_ca":true},{"name":"Georgina V. Long","is_ca":false},{"name":"Anthony M. Joshua","is_ca":false},{"name":"Brooke Shankles","is_ca":false},{"name":"Umut Y. Ulge","is_ca":false},{"name":"Andrew Weickhardt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01861948697596352,"gpt":0.2867674058962363,"spread":0.2681479189202728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002366892,0.0002146828,0.0004825123,0.0001612407,0.0000618055,0.00002022794,0.00006929004,0.0001193664,0.00007826136],"category_scores_gemma":[0.0001087646,0.0001623107,0.0000475906,0.0003908362,0.0001696157,0.0001362317,0.000025552,0.0002482265,7.111855e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001644285,"about_ca_system_score_gemma":0.0005133568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001928508,"about_ca_topic_score_gemma":0.006107031,"domain_scores_codex":[0.9983554,0.00006480832,0.0005357814,0.0003913394,0.0003838472,0.000268781],"domain_scores_gemma":[0.9990619,0.00003477028,0.0001934363,0.0003596643,0.0001180366,0.0002321987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005320512,0.004547309,0.9707889,0.0003559169,0.0002554292,0.0005395954,0.00315324,0.00002273583,0.01245791,0.000005321386,0.0006067403,0.001946387],"study_design_scores_gemma":[0.02922886,0.002494107,0.9569114,0.000938269,0.0001052542,0.00001682674,0.000901679,0.000008541108,0.006977008,0.0000121227,0.002183119,0.0002227725],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997993,0.0007708432,2.906413e-7,0.0003184617,0.000135427,0.0006187671,0.00001859379,0.00001920414,0.0001253991],"genre_scores_gemma":[0.9990206,0.000126932,0.00007014182,0.0002122076,0.00004087336,0.00004343894,0.0000345659,0.00003116812,0.0004200918],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02390835,"threshold_uncertainty_score":0.6618838,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3214459545","doi":"10.1136/jitc-2021-sitc2021.538","title":"538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Melanoma; Refractory (planetary science); Internal medicine; Gastroenterology; Nuclear medicine; Urology; Surgery; Oncology; Cancer research; Biology","authors":[{"name":"Joseph J. Sacco","is_ca":false},{"name":"Richard D. Carvajal","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Alexander N. Shoushtari","is_ca":false},{"name":"Jessica C. Hassel","is_ca":false},{"name":"Alexandra P. Ikeguchi","is_ca":false},{"name":"Leonel F. Hernandez‐Aya","is_ca":false},{"name":"Paul Nathan","is_ca":false},{"name":"Omid Hamid","is_ca":false},{"name":"Josep M. Piulats","is_ca":false},{"name":"Matthew J. Rioth","is_ca":false},{"name":"Jason J. Luke","is_ca":false},{"name":"Enrique Espinosa","is_ca":false},{"name":"Serge Leyvraz","is_ca":false},{"name":"Chris Holland","is_ca":false},{"name":"Michelle L. McCully","is_ca":false},{"name":"Shaad E. Abdullah","is_ca":false},{"name":"Takami Sato","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01325478381405026,"gpt":0.2431491939966965,"spread":0.2298944101826462,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000198927,0.000305164,0.0007420658,0.00009309692,0.0001030906,0.00002374153,0.00006638923,0.0001563073,0.00007643823],"category_scores_gemma":[0.0002080056,0.0002340443,0.0001054412,0.0002760123,0.000324054,0.000142239,0.00003913901,0.0002021027,0.00001376003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007555753,"about_ca_system_score_gemma":0.0004791718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001032096,"about_ca_topic_score_gemma":0.0001095118,"domain_scores_codex":[0.9981422,0.000184924,0.0004624827,0.0004551677,0.0003978414,0.000357319],"domain_scores_gemma":[0.9984321,0.00005159528,0.0002446484,0.0003914181,0.0003223708,0.0005578778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004655142,0.0007915306,0.9928583,0.0002019685,0.001303516,0.0008367474,0.0002835318,0.000008279514,0.001936733,0.00009295926,0.0005404758,0.0006804458],"study_design_scores_gemma":[0.006925428,0.0009462544,0.9527004,0.0002682658,0.001331426,0.0001479262,0.0001194311,0.00002069464,0.03549156,0.0001177772,0.001694003,0.0002368616],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972556,0.0004885159,0.000004891883,0.0003773514,0.0001290558,0.0005275789,0.00007075647,0.0000545872,0.001091662],"genre_scores_gemma":[0.996305,0.00007239325,0.001259179,0.0001651374,0.0000288,0.00001621267,0.0009800671,0.00004162025,0.001131519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04015793,"threshold_uncertainty_score":0.954405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388047619","doi":"10.1136/jitc-2023-sitc2023.0778","title":"778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Cancer; Internal medicine; Oncology; Surgery; Immunotherapy; Cancer research","authors":[{"name":"Daniel J. Olson","is_ca":false},{"name":"James Larkin","is_ca":false},{"name":"Young Ki Hong","is_ca":false},{"name":"Sajeve Thomas","is_ca":false},{"name":"Juan Martín-Liberal","is_ca":false},{"name":"Andrew J.S. Furness","is_ca":false},{"name":"Patrick Terheyden","is_ca":false},{"name":"Gino K. In","is_ca":false},{"name":"Andrew Poklepovic","is_ca":false},{"name":"Yazan Samhouri","is_ca":false},{"name":"Philip E. Lammers","is_ca":false},{"name":"Victoria Atkinson","is_ca":false},{"name":"Idit Peretz","is_ca":false},{"name":"Marcus O. Butler","is_ca":true},{"name":"Friedrich Graf Finckenstein","is_ca":false},{"name":"Jeffrey Chou","is_ca":false},{"name":"Xiao Wu","is_ca":false},{"name":"Giri Sulur","is_ca":false},{"name":"Wen Shi","is_ca":false},{"name":"John B.A.G. Haanen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04680987990646559,"gpt":0.3167563591817601,"spread":0.2699464792752946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008332377,0.0006795656,0.001498428,0.0006646824,0.0002033568,0.0001197015,0.0002592789,0.0001308498,0.0002199782],"category_scores_gemma":[0.0002598752,0.0004904941,0.0001591771,0.001479921,0.0003957777,0.0002957295,0.00007189978,0.0003978394,0.00002705014],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000396103,"about_ca_system_score_gemma":0.001659521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002294102,"about_ca_topic_score_gemma":0.000772726,"domain_scores_codex":[0.9955819,0.0003560807,0.001033492,0.0009229711,0.00109182,0.00101379],"domain_scores_gemma":[0.9971659,0.0004370276,0.0004030165,0.0008994964,0.0002240455,0.0008705383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.08262718,0.01303833,0.07585815,0.001727283,0.001993002,0.01113614,0.01794103,0.001208886,0.7816778,0.00004844465,0.001093923,0.01164979],"study_design_scores_gemma":[0.2165749,0.05501272,0.0678672,0.001080115,0.0006370976,0.001033996,0.01105502,0.005960967,0.6359932,0.000167736,0.003288739,0.001328303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942449,0.0008478409,0.000002604066,0.0002012539,0.00011031,0.003005099,0.00005666526,0.0001777147,0.001353642],"genre_scores_gemma":[0.9922957,0.0007857413,0.0004036712,0.0001140943,0.0000929589,0.0003522287,0.0001203009,0.000156502,0.005678794],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1456846,"threshold_uncertainty_score":0.9997547,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048272","doi":"10.1136/jitc-2023-sitc2023.0766","title":"766 A clinical trial to evaluate the safety, tolerability and preliminary efficacy of VG161 in combination with Nivolumab in patients with advanced pancreatic cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Tolerability; Medicine; Pharmacodynamics; Nivolumab; Oncolytic virus; Internal medicine; Pharmacokinetics; Gastroenterology; Refractory (planetary science); Pancreatic cancer; Adverse effect; Cancer; Oncology; Urology; Pharmacology; Immunotherapy; Biology","authors":[{"name":"Yinan Shen","is_ca":false},{"name":"Aijun Qin","is_ca":false},{"name":"Yiting Qiu","is_ca":false},{"name":"Xinyan Jin","is_ca":false},{"name":"Wei Song","is_ca":false},{"name":"Fang Tian","is_ca":false},{"name":"Xingmei Liang","is_ca":false},{"name":"Yuwei Li","is_ca":false},{"name":"David S.P. Tan","is_ca":false},{"name":"Ronghua Zhao","is_ca":true},{"name":"Xueli Bai","is_ca":false},{"name":"Tingbo Liang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02569682065945692,"gpt":0.331014626253827,"spread":0.3053178055943701,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001221274,0.0001561352,0.0002907446,0.00007780593,0.00005618716,0.0000184257,0.0001274835,0.0001054693,0.000001846837],"category_scores_gemma":[0.0004801233,0.000107675,0.00003043139,0.0002944203,0.0003153007,0.00001172514,0.00007883116,0.000160871,8.556515e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003309936,"about_ca_system_score_gemma":0.0003223995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001234242,"about_ca_topic_score_gemma":0.0007323331,"domain_scores_codex":[0.9982963,0.0002962856,0.0004290948,0.0004152003,0.0003111491,0.0002519625],"domain_scores_gemma":[0.9991898,0.00009106525,0.00009636866,0.0003374458,0.0001100904,0.0001752181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2300645,0.0007121649,0.7334768,0.0001376861,0.0001319299,0.000009481157,0.0005522766,0.003578611,0.01305795,0.00001041955,0.0001193871,0.01814881],"study_design_scores_gemma":[0.03042618,0.01089403,0.9492078,0.0001435097,0.00002520434,0.000001161637,0.00005255748,0.0001339873,0.008837946,0.00005748295,0.00007060102,0.000149575],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977489,0.0002037692,0.000002401771,0.0005747649,0.00004946378,0.001382341,0.00001478466,0.000008343606,0.00001530134],"genre_scores_gemma":[0.9994335,0.0001681943,0.00008084943,0.00008165961,0.00002977363,0.0001043902,0.00004976281,0.00002116664,0.00003072982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.215731,"threshold_uncertainty_score":0.4390859,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3103926827","doi":"10.1136/jitc-2020-sitc2020.0155","title":"155 iPSC-derived NK cells mediate robust anti-tumor activity against glioblastoma","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Cancer research; Immunotherapy; Adoptive cell transfer; NK-92; Cytotoxicity; Perforin; Biology; Immunology; Interleukin 21; Immune system; CD8; T cell; In vitro","authors":[{"name":"Jeffrey S. Miller","is_ca":false},{"name":"Frank Cichocki","is_ca":false},{"name":"Jianfang Ning","is_ca":false},{"name":"Ryan Bjordahl","is_ca":false},{"name":"Zachary Davis","is_ca":false},{"name":"Katie Tuininga","is_ca":false},{"name":"Hongbo Wang","is_ca":false},{"name":"Paul Rogers","is_ca":false},{"name":"Moyar Ge","is_ca":false},{"name":"Tom Lee","is_ca":false},{"name":"Bob Valamehr","is_ca":false},{"name":"Clark Chen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03077527250515736,"gpt":0.2557324741213075,"spread":0.2249572016161501,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004789588,0.0004706506,0.0007854898,0.000156024,0.0002038475,0.0001468995,0.0002416022,0.0002454648,0.0002439108],"category_scores_gemma":[0.0005621455,0.0004368229,0.0002241893,0.0004465927,0.0006182975,0.000288569,0.0001555374,0.0008181664,0.0001584226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001169631,"about_ca_system_score_gemma":0.00061004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006286561,"about_ca_topic_score_gemma":0.00002060964,"domain_scores_codex":[0.9968407,0.0001502856,0.0004771126,0.0008232445,0.000919016,0.0007896579],"domain_scores_gemma":[0.9965672,0.0001051715,0.0002032743,0.0005435189,0.0001682855,0.002412495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003834572,0.0001271896,0.002594433,0.0004542587,0.0001420795,0.001293103,0.0005437895,0.0002263269,0.9877215,0.0000129831,0.00406427,0.002436621],"study_design_scores_gemma":[0.002685297,0.0005894923,0.03113322,0.0002360673,0.0001255612,0.0002476275,0.0002074775,0.002917382,0.9470398,0.00003688693,0.01423937,0.0005418612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904399,0.0003266803,0.00003463042,0.005609647,0.000330044,0.0007528602,0.00003716172,0.0002661894,0.002202919],"genre_scores_gemma":[0.9949847,0.0004841087,0.0004733313,0.002522776,0.0007367748,0.00002427609,0.00002744411,0.0001145874,0.0006320299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04068173,"threshold_uncertainty_score":0.9998084,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3103606205","doi":"10.1136/jitc-2020-sitc2020.0307","title":"307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"Pritzker School of Medicine; American Society of Hematology","keywords":"Vemurafenib; Internal medicine; Medicine; Atezolizumab; Hazard ratio; Oncology; Progression-free survival; Melanoma; Pembrolizumab; Immunotherapy; Cancer research; Cancer; Overall survival; Metastatic melanoma; Confidence interval","authors":[{"name":"Karl D. Lewis","is_ca":false},{"name":"Paolo A. Ascierto","is_ca":false},{"name":"Caroline Robert","is_ca":false},{"name":"Rodrigo Ramella Munhoz","is_ca":false},{"name":"Gabriella Liszkay","is_ca":false},{"name":"Luis De La Cruz Marino","is_ca":false},{"name":"Judit Oláh","is_ca":false},{"name":"Paola Queirolo","is_ca":false},{"name":"Jacek Mackiewicz","is_ca":false},{"name":"Kalpit Shah","is_ca":false},{"name":"Harper Forbes","is_ca":true},{"name":"Christian Hertig","is_ca":true},{"name":"Yibing Yan","is_ca":false},{"name":"Ralf Gutzmer","is_ca":false},{"name":"Grant A. McArthur","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00991258563327047,"gpt":0.2194322897048243,"spread":0.2095197040715538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003204795,0.0002630069,0.0003215451,0.0000500689,0.00009292835,0.0000882907,0.0001215041,0.0001143253,9.033142e-7],"category_scores_gemma":[0.0001693591,0.0001856868,0.00002306563,0.0001035976,0.000156756,0.0000288655,0.00007049189,0.000194848,6.943601e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001473184,"about_ca_system_score_gemma":0.000182808,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001914675,"about_ca_topic_score_gemma":0.0001731319,"domain_scores_codex":[0.998522,0.0001585946,0.0003221775,0.0004901717,0.0002494952,0.0002575422],"domain_scores_gemma":[0.9993579,0.00002486434,0.0001414649,0.0001974537,0.00005317778,0.0002251621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001265765,0.0004468828,0.8311512,0.0003505335,0.0001638609,0.0004639478,0.006628434,0.0002602345,0.1577966,0.0000936368,0.0001232426,0.001255647],"study_design_scores_gemma":[0.01076583,0.002644567,0.9472007,0.00005656876,0.00007808321,0.00003404655,0.001953762,0.0001168968,0.03594697,0.00008115986,0.0006322903,0.0004891808],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979126,0.0003601926,0.000003363618,0.0004195113,0.00005130564,0.001174184,0.00003619383,0.00001444178,0.00002819814],"genre_scores_gemma":[0.9993359,0.00001385133,0.0001439757,0.0001952841,0.00008965655,0.00005668606,0.0001179809,0.00002587112,0.00002075943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1218496,"threshold_uncertainty_score":0.7572089,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308385775","doi":"10.1136/jitc-2022-sitc2022.0750","title":"750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Gastroenterology; Oncology; Cancer; Immunotherapy","authors":[{"name":"Kyriakos Papadopoulos","is_ca":false},{"name":"Siqing Fu","is_ca":false},{"name":"Erika Hamilton","is_ca":false},{"name":"Alexander I. Spira","is_ca":false},{"name":"Scott A. Laurie","is_ca":true},{"name":"Judy Wang","is_ca":false},{"name":"Brigette Ma","is_ca":false},{"name":"Anna Spreafico","is_ca":true},{"name":"Manish Sharma","is_ca":false},{"name":"Quincy S. Chu","is_ca":false},{"name":"Mark Bray","is_ca":false},{"name":"Glenn Michelson","is_ca":false},{"name":"Dih-Yih Chen","is_ca":false},{"name":"Linh Nguyen","is_ca":false},{"name":"Emily Roberts-Thomson","is_ca":false},{"name":"Omid Hamid","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01073260727766131,"gpt":0.2477301152551453,"spread":0.236997507977484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002908251,0.0002623039,0.0003918128,0.000179952,0.00009411591,0.00004198711,0.0001169683,0.0000870669,0.000003466854],"category_scores_gemma":[0.0001552922,0.0002548622,0.00003205127,0.0002749412,0.000176027,0.00001907398,0.0001405042,0.0001827946,3.911236e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009814185,"about_ca_system_score_gemma":0.0003648583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003756802,"about_ca_topic_score_gemma":0.003842453,"domain_scores_codex":[0.998261,0.00008602057,0.0004914268,0.0005480397,0.0002875862,0.0003259387],"domain_scores_gemma":[0.9991816,0.00003976293,0.0002367565,0.0002861742,0.00006719393,0.0001885228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.009307068,0.014243,0.3700204,0.001040106,0.0002354843,0.001773718,0.01227078,0.006863162,0.5825595,0.0001322288,0.0003131748,0.001241349],"study_design_scores_gemma":[0.06886103,0.03769002,0.231803,0.001115638,0.0002238988,0.0008292262,0.0169227,0.0004416007,0.6366526,0.0007180544,0.002831288,0.001910921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972238,0.001387884,0.000002379501,0.0001460674,0.00008508072,0.001059902,0.00002470437,0.000008676064,0.00006149092],"genre_scores_gemma":[0.9991959,0.0001353193,0.0001562434,0.00008100616,0.0000291288,0.0002722998,0.00004922753,0.00003876441,0.00004216333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1382174,"threshold_uncertainty_score":0.9999903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3103244011","doi":"10.1136/jitc-2020-sitc2020.0351","title":"351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Oncology; Immunotherapy; Head and neck squamous-cell carcinoma; Chemotherapy; Internal medicine; Head and neck cancer; Head and neck; Radiation therapy; Surgery; Cancer","authors":[{"name":"Kevin J. Harrington","is_ca":false},{"name":"Ezra E.W. Cohen","is_ca":false},{"name":"L.L. Siu","is_ca":true},{"name":"Danny Rischin","is_ca":false},{"name":"Lisa Licitra","is_ca":false},{"name":"Jan B. Vermorken","is_ca":false},{"name":"Quynh‐Thu Le","is_ca":false},{"name":"Makoto Tahara","is_ca":false},{"name":"Jean‐Pascal Machiels","is_ca":false},{"name":"Natalyn Hawk","is_ca":false},{"name":"Joy Yang Ge","is_ca":false},{"name":"Behzad Bidadi","is_ca":false},{"name":"Ramona F. Swaby","is_ca":false},{"name":"Barbara Burtness","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04785480680630224,"gpt":0.2749732537829019,"spread":0.2271184469765996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004081471,0.0007644002,0.001033279,0.0001602929,0.0003593605,0.0002556798,0.0001500988,0.0002756341,0.00002660205],"category_scores_gemma":[0.00008447516,0.0006462506,0.0001752442,0.0002236778,0.0006895479,0.0002665256,0.00003319652,0.0004218906,0.000001659703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008105351,"about_ca_system_score_gemma":0.0003443804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001350285,"about_ca_topic_score_gemma":0.00001733722,"domain_scores_codex":[0.9970084,0.0001125168,0.0007154723,0.001040891,0.0004644794,0.0006581715],"domain_scores_gemma":[0.998082,0.0002322105,0.0004285347,0.0004234152,0.0000914569,0.0007424142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1546488,0.00143903,0.1268786,0.005366894,0.001579319,0.0002186919,0.03652987,0.00002214508,0.3291618,0.0004675272,0.009133747,0.3345536],"study_design_scores_gemma":[0.1382737,0.02696918,0.5641825,0.001031962,0.0003397747,0.0006627904,0.001777851,0.003138675,0.1851719,0.0008580867,0.0750327,0.002560811],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9650548,0.02307801,0.00003311968,0.008710152,0.0001763773,0.002583707,0.00009404546,0.0001376019,0.0001321582],"genre_scores_gemma":[0.9835534,0.005736013,0.002357332,0.007487939,0.0002448712,0.0001764851,0.00008322606,0.0001688876,0.0001918641],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4373039,"threshold_uncertainty_score":0.9995989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308383460","doi":"10.1136/jitc-2022-sitc2022.1185","title":"1185 Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nuvation (Canada); Zymeworks (Canada)","funders":"","keywords":"Immune system; TLR7; Purine; Pharmacology; Antibody; Peripheral blood mononuclear cell; Splenocyte; In vitro; Chemistry; Cytokine; Cancer research; Immunology; Biology; Biochemistry; Toll-like receptor; Innate immune system","authors":[{"name":"Graham A. E. Garnett","is_ca":true},{"name":"Katina Mak","is_ca":true},{"name":"Renee Duan","is_ca":true},{"name":"Truman Hirkala-Schaefer","is_ca":true},{"name":"Manuel Lasalle","is_ca":true},{"name":"Nichole Escalante","is_ca":true},{"name":"Joy Guedia","is_ca":true},{"name":"Kara White Moyes","is_ca":true},{"name":"Sam Lawn","is_ca":true},{"name":"Raffaele Colombo","is_ca":true},{"name":"Jamie Rich","is_ca":true},{"name":"Stuart D. Barnscher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02088711229255909,"gpt":0.3131224107280727,"spread":0.2922352984355136,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003379688,0.0001886822,0.0003437816,0.00005734548,0.0003144462,0.00003091891,0.0001084271,0.00008251701,0.000079795],"category_scores_gemma":[0.0003876233,0.0001918613,0.0001272381,0.0001907368,0.0002532743,0.00006779864,0.00004518326,0.0002245924,0.000001975359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005485559,"about_ca_system_score_gemma":0.0002791597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002169467,"about_ca_topic_score_gemma":1.234095e-7,"domain_scores_codex":[0.9985966,0.00003168696,0.0004905261,0.0003236234,0.0002942907,0.0002632547],"domain_scores_gemma":[0.9988897,0.0001270796,0.0002160992,0.0002818606,0.0001169765,0.0003683024],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002168639,0.0002413263,0.003884804,0.0006687391,0.00009265345,0.00002096592,0.0001346716,0.08482493,0.9084727,0.00086794,0.0003967021,0.0001776748],"study_design_scores_gemma":[0.003440652,0.0004062372,0.005236279,0.0001534415,0.0003486089,0.0001832465,0.0001750173,0.09621479,0.8813624,0.0009735471,0.01114397,0.0003617924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992038,0.0007683769,0.001707696,0.003432763,0.0001058094,0.0007867293,0.0001005563,0.00009215443,0.0009679866],"genre_scores_gemma":[0.9924974,0.00002154068,0.006046186,0.000325091,0.00009306076,0.000101473,0.0004840119,0.00003417568,0.0003969885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02711031,"threshold_uncertainty_score":0.7823879,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3212274217","doi":"10.1136/jitc-2021-sitc2021.374","title":"374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Sanofi","keywords":"Pembrolizumab; Aflibercept; Medicine; Oncology; Internal medicine; Cancer; Bevacizumab; Immunotherapy; Chemotherapy","authors":[{"name":"Kevin Tyan","is_ca":false},{"name":"Osama E. Rahma","is_ca":false},{"name":"Anita Giobbie‐Hurder","is_ca":false},{"name":"Andrew S. Brohl","is_ca":false},{"name":"Philippe L. Bédard","is_ca":true},{"name":"Daniel J. Renouf","is_ca":false},{"name":"Elad Sharon","is_ca":false},{"name":"Howard Streicher","is_ca":false},{"name":"Emma Hathaway","is_ca":false},{"name":"Rachel Cunningham","is_ca":false},{"name":"Michael P. Manos","is_ca":false},{"name":"Mariano Severgnini","is_ca":false},{"name":"Scott J. Rodig","is_ca":false},{"name":"F. Stephen Hodi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01062840677381271,"gpt":0.2660235208790911,"spread":0.2553951141052784,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002005294,0.0002500878,0.0006296302,0.0001277027,0.00005550737,0.00002637896,0.00007377224,0.0001322861,0.00004086946],"category_scores_gemma":[0.0001831803,0.0002087789,0.0001165818,0.0003248025,0.0003141531,0.000164187,0.00002853302,0.000219072,0.000002283406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001351137,"about_ca_system_score_gemma":0.0009582291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009225078,"about_ca_topic_score_gemma":0.00005431468,"domain_scores_codex":[0.9981542,0.00005915497,0.000605423,0.0003974261,0.0004527041,0.0003310879],"domain_scores_gemma":[0.9988559,0.00003059549,0.0002382453,0.0003729157,0.0001555826,0.0003468001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6637543,0.007362552,0.07087082,0.001969299,0.001403776,0.00159183,0.006498393,0.0002783503,0.191863,0.0002138407,0.002491782,0.05170208],"study_design_scores_gemma":[0.4736041,0.005406834,0.4152679,0.001591241,0.0002519339,0.0001705164,0.0005247191,0.00007502394,0.09821729,0.0001308777,0.00414113,0.0006184206],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975437,0.0005818963,0.000004401092,0.0003630329,0.0002358143,0.0006689202,0.00003090154,0.00003263995,0.0005386813],"genre_scores_gemma":[0.9985316,0.0001047224,0.0004676798,0.0003237866,0.00007825277,0.00002688366,0.0001079054,0.00003739672,0.0003217266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3443971,"threshold_uncertainty_score":0.8513758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042546","doi":"10.1136/jitc-2023-sitc2023.0601","title":"601 Identification of non-squamous NSCLC molecular subtypes and association with outcomes in the phase 3 IMpower150 study of 1L atezolizumab ± bevacizumab + carboplatin-paclitaxel in metastatic NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Carboplatin; Atezolizumab; Bevacizumab; Medicine; Internal medicine; Paclitaxel; Oncology; Population; Chemotherapy; Cancer research; Cancer; Immunotherapy; Cisplatin; Nivolumab","authors":[{"name":"Tianshi Lü","is_ca":false},{"name":"Mark A. Socinski","is_ca":false},{"name":"Martin Reck","is_ca":false},{"name":"Howard West","is_ca":false},{"name":"Federico Cappuzzo","is_ca":false},{"name":"Fabrice Barlési","is_ca":false},{"name":"Robert M. Jotte","is_ca":false},{"name":"Sören Müller","is_ca":false},{"name":"Habib Hamidi","is_ca":false},{"name":"Assaf Amitai","is_ca":false},{"name":"Hartmut Koeppen","is_ca":false},{"name":"David S. Shames","is_ca":false},{"name":"Marcus Ballinger","is_ca":false},{"name":"Aditi Qamra","is_ca":true},{"name":"Minu K. Srivastava","is_ca":false},{"name":"Barzin Y. Nabet","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0100293777047789,"gpt":0.2723889858369495,"spread":0.2623596081321706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000749696,0.0001720804,0.0003150965,0.0001365895,0.00004055709,0.00003700569,0.0001256835,0.00009270688,4.265518e-7],"category_scores_gemma":[0.0005909773,0.0001399678,0.00004165587,0.0002625219,0.00009152024,0.00001314971,0.00005068195,0.0001066504,5.179706e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003497257,"about_ca_system_score_gemma":0.000147598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007133413,"about_ca_topic_score_gemma":0.001014625,"domain_scores_codex":[0.9985707,0.0001026215,0.0005236838,0.0003119114,0.0002809559,0.0002100581],"domain_scores_gemma":[0.9990841,0.0001014082,0.0003394996,0.000309447,0.0000856616,0.0000798819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0003055593,0.0008174787,0.3997148,0.0001905723,0.0002326205,0.00007994342,0.004396448,0.001489306,0.5917275,0.0001010078,0.0001451557,0.0007996671],"study_design_scores_gemma":[0.006488288,0.001154266,0.8415901,0.00005736043,0.0001746523,0.00001621774,0.00390331,0.0004419156,0.1454916,0.0003496579,0.00004907346,0.0002835607],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986771,0.000395965,0.00001737789,0.0001792736,0.00006094141,0.0005642587,0.00006347711,0.000005329488,0.00003630656],"genre_scores_gemma":[0.9996036,0.0001204087,0.00005869239,0.00004065671,0.00001402594,0.00004341281,0.00007654876,0.00001974739,0.00002288803],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4462359,"threshold_uncertainty_score":0.5707723,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308407496","doi":"10.1136/jitc-2022-sitc2022.1071","title":"1071 Autologous tumor cell immunotherapeutic platform induces stress-correlated immunogenic cell death leading to immune activation within the draining lymph nodes","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Flow cytometry; Immunophenotyping; Cancer research; Immune system; Programmed cell death; Medicine; Apoptosis; Chemistry; Immunology","authors":[{"name":"Christopher Cultrara","is_ca":false},{"name":"Kenneth W. Kirby","is_ca":false},{"name":"Essam Elrazaq","is_ca":false},{"name":"Christopher Uhl","is_ca":false},{"name":"Amelia Zellander","is_ca":false},{"name":"Lorenzo Galluzzi","is_ca":false},{"name":"Mark A. Exley","is_ca":false},{"name":"Jenny Zilberberg","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02217041544240454,"gpt":0.2453659956535131,"spread":0.2231955802111086,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005636417,0.0004084471,0.0005014695,0.0002289936,0.0009768774,0.0001512488,0.0002473289,0.0001181668,0.00004127094],"category_scores_gemma":[0.0001108079,0.0003141223,0.0001681085,0.0004143828,0.0001456371,0.000205463,0.0001658691,0.0005132941,0.00002985614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003871931,"about_ca_system_score_gemma":0.0004331825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006669689,"about_ca_topic_score_gemma":0.000005112735,"domain_scores_codex":[0.9976884,0.00009844352,0.0006393011,0.0005172386,0.0005427355,0.0005139411],"domain_scores_gemma":[0.9984945,0.0001576884,0.0004052321,0.0005380744,0.0000757304,0.0003287973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002529692,0.000512775,0.02894824,0.0001277087,0.0003659299,0.0003017763,0.006072628,0.00434913,0.9577129,0.0002403728,0.00008007584,0.001035451],"study_design_scores_gemma":[0.002997268,0.0004761271,0.2229612,0.0003137261,0.0004404778,0.0006273641,0.004608857,0.0006864218,0.7655758,0.0003018983,0.0005152436,0.0004956406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942791,0.002687022,0.000006660697,0.001055056,0.0004064508,0.0007497887,0.00002500203,0.0001385684,0.0006523687],"genre_scores_gemma":[0.9979324,0.00003949533,0.0003827204,0.0008765202,0.00006519205,0.0002077907,0.0001029594,0.00007818265,0.0003146875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1940129,"threshold_uncertainty_score":0.9999311,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3101543312","doi":"10.1136/jitc-2020-sitc2020.0727","title":"727 Increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"TIGIT; Cancer research; Antibody; Cytokine; Hepatocellular carcinoma; Proinflammatory cytokine; Tumor microenvironment; Immune system; Biology; Medicine; Molecular biology; Immunology; T cell; Inflammation","authors":[{"name":"Matthew Rausch","is_ca":false},{"name":"Devapregasan Moodley","is_ca":false},{"name":"Marisa O. Peluso","is_ca":false},{"name":"Secil Koseoglu","is_ca":false},{"name":"Jing Hua","is_ca":false},{"name":"Gege Tan","is_ca":false},{"name":"Ricard Masia","is_ca":false},{"name":"Benjamin Lee","is_ca":false},{"name":"Isabelle Cousineau","is_ca":true},{"name":"Simon Turcotte","is_ca":true},{"name":"John Stagg","is_ca":true},{"name":"Vito J. Palombella","is_ca":false},{"name":"Pamela M. Holland","is_ca":false},{"name":"Jonathan A. Hill","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02249317592307051,"gpt":0.2240064407249474,"spread":0.2015132648018769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004490028,0.0002957058,0.0007089576,0.0001534892,0.0000619027,0.00002077303,0.0001168745,0.000152354,0.000008611059],"category_scores_gemma":[0.0005365951,0.0002149046,0.0000880442,0.0004963267,0.000389228,0.000125396,0.00006957367,0.0002908743,4.407888e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009805158,"about_ca_system_score_gemma":0.0001990401,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001847465,"about_ca_topic_score_gemma":0.0004515692,"domain_scores_codex":[0.9980083,0.0001053103,0.0007361396,0.000377273,0.000445597,0.0003273576],"domain_scores_gemma":[0.9987668,0.0001039265,0.0004898884,0.0001891659,0.0001574946,0.000292661],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005361879,0.0001518725,0.9765156,0.0006507864,0.000116771,0.0001840623,0.001219132,0.000004863386,0.02051385,0.000009457616,0.00003624752,0.00006118421],"study_design_scores_gemma":[0.005393146,0.0004242416,0.9297091,0.001244486,0.0001062767,0.00002799491,0.0002481945,0.0006548507,0.06192373,0.0000150192,0.00003358583,0.0002193599],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996295,0.0006061092,8.759733e-7,0.002178949,0.00004208945,0.0006675317,0.0001569838,0.00002039725,0.00003203708],"genre_scores_gemma":[0.9990776,0.00005413226,0.0000428385,0.0007052981,0.00002635399,0.000007497667,0.00002938468,0.00003607431,0.00002087118],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04680647,"threshold_uncertainty_score":0.8763558,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048274","doi":"10.1136/jitc-2023-sitc2023.0277","title":"277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer research; Glioma; Immunotherapy; Chimeric antigen receptor; Tumor microenvironment; Flow cytometry; Immune system; Epidermal growth factor receptor; Antigen; Cytotoxic T cell; Brain tumor; Biology; Immunology; Medicine; Receptor; Pathology; Internal medicine; In vitro","authors":[{"name":"Senthilnath Lakshmanachetty","is_ca":false},{"name":"Milos Simic","is_ca":false},{"name":"Payal Watchmaker","is_ca":false},{"name":"Akane Yamamichi","is_ca":false},{"name":"Tiffany Chen","is_ca":false},{"name":"Su Phyu","is_ca":false},{"name":"Takahide Nejo","is_ca":false},{"name":"Chanelle Shepherd","is_ca":false},{"name":"Jason Duecker","is_ca":false},{"name":"Yuan Wang","is_ca":false},{"name":"Olga G. Troyanskaya","is_ca":false},{"name":"Lia Cardarelli","is_ca":true},{"name":"Sachdev S. Sidhu","is_ca":true},{"name":"Wendell A. Lim","is_ca":false},{"name":"Hideho Okada","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04880684535185395,"gpt":0.3212046304507716,"spread":0.2723977850989177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001462089,0.000423488,0.0008307323,0.0004082054,0.0001555829,0.0001150279,0.0002529208,0.0002724511,0.00002337446],"category_scores_gemma":[0.0005633532,0.0003911723,0.0003395813,0.0005028861,0.0004669799,0.0001539616,0.0001403656,0.0006435439,0.00007333626],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001559062,"about_ca_system_score_gemma":0.0007372861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007193549,"about_ca_topic_score_gemma":0.00003709058,"domain_scores_codex":[0.9964436,0.0001159775,0.0009534693,0.0008250143,0.0006785159,0.0009833813],"domain_scores_gemma":[0.9976794,0.0002878883,0.0001795815,0.0006795624,0.0001657946,0.001007751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008185664,0.000502035,0.00234093,0.0004764065,0.0001932957,0.000359507,0.0004732239,0.005271928,0.9855669,0.00009506848,0.00135878,0.002543372],"study_design_scores_gemma":[0.01197369,0.001338641,0.08728997,0.0009517263,0.0002707207,0.0003941027,0.0003694509,0.2047008,0.6869591,0.0008530629,0.003840618,0.001058077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954162,0.0002709513,0.00006351903,0.001534043,0.0002363213,0.002022721,0.00007587937,0.0002482783,0.0001321342],"genre_scores_gemma":[0.9936308,0.0003930432,0.001412642,0.0003635834,0.0001853709,0.0001703645,0.00005992677,0.000120745,0.003663555],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2986077,"threshold_uncertainty_score":0.999854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388083490","doi":"10.1136/jitc-2023-sitc2023.0783","title":"783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Stand Up To Cancer","keywords":"Ipilimumab; Medicine; Nivolumab; Internal medicine; Immunotherapy; Progression-free survival; Oncology; Melanoma; Progressive disease; Chemotherapy; Cancer research; Cancer","authors":[{"name":"Anirban Das","is_ca":true},{"name":"Nicholas Fernandez","is_ca":true},{"name":"Adrian Levine","is_ca":true},{"name":"Vanessa Bianchi","is_ca":true},{"name":"Lucie Stengs","is_ca":true},{"name":"Melissa Edwards","is_ca":true},{"name":"Trevor J. Pugh","is_ca":true},{"name":"Derek S. Tsang","is_ca":true},{"name":"Birgit Ertl‐Wagner","is_ca":true},{"name":"Daniel A. Morgenstern","is_ca":true},{"name":"Cynthia Hawkins","is_ca":true},{"name":"Éric Bouffet","is_ca":true},{"name":"Uri Tabori","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03118325356358788,"gpt":0.293107385921724,"spread":0.2619241323581362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007969531,0.000319967,0.0004838574,0.0001507659,0.0002789071,0.0001498288,0.0001933424,0.0001660746,0.00001023114],"category_scores_gemma":[0.0007159416,0.000230989,0.000303493,0.0002770047,0.0002124841,0.0001295026,0.00005399611,0.0001642007,0.00001540656],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001235173,"about_ca_system_score_gemma":0.0001822683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007674894,"about_ca_topic_score_gemma":0.00003115169,"domain_scores_codex":[0.9974552,0.00004262152,0.0008584798,0.0007877306,0.0004860311,0.0003699189],"domain_scores_gemma":[0.9977714,0.0002873348,0.0004327644,0.00105258,0.0001847785,0.0002710854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0003580872,0.0005442435,0.3711526,0.00008944775,0.001329314,0.000722003,0.0006249162,0.00008597895,0.608745,0.001334663,0.01275631,0.00225737],"study_design_scores_gemma":[0.004595698,0.0002206539,0.8392689,0.0001562113,0.0002495468,0.000289015,0.000278855,0.001475666,0.1347474,0.001668693,0.01674555,0.0003038159],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782488,0.0008363287,0.00004291514,0.01821814,0.0008136927,0.001295256,0.0001040734,0.0003959317,0.00004483189],"genre_scores_gemma":[0.9951338,0.0002578359,0.001805732,0.001094205,0.0002550039,0.000358532,0.0007529419,0.00006780124,0.0002741386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4739977,"threshold_uncertainty_score":0.9419459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388077811","doi":"10.1136/jitc-2023-sitc2023.0760","title":"760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Adverse effect; Pharmacokinetics; Internal medicine; Dosing; Toxicity; Response Evaluation Criteria in Solid Tumors; Melanoma; Gastroenterology; Oncology; Pharmacology; Phases of clinical research; Urology; Cancer research","authors":[{"name":"Minh D. To","is_ca":false},{"name":"Rosemina Merchant","is_ca":false},{"name":"Victoria Atkinson","is_ca":false},{"name":"Philippe L. Bédard","is_ca":true},{"name":"Warren Brenner","is_ca":false},{"name":"Melissa Coello","is_ca":false},{"name":"Jesús Fuentes‐Antrás","is_ca":true},{"name":"Carole L. Galligan","is_ca":false},{"name":"Charlotte Lemech","is_ca":false},{"name":"Peter Lloyd","is_ca":false},{"name":"Sudhir Madduri Karanam","is_ca":false},{"name":"Kim Margolin","is_ca":false},{"name":"Matthen Mathew","is_ca":false},{"name":"Amy Prawira","is_ca":false},{"name":"Sajeve Thomas","is_ca":false},{"name":"Przemyslaw Twardowski","is_ca":false},{"name":"Arash Yavari","is_ca":false},{"name":"Fahar Merchant","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02524647422427279,"gpt":0.3088298909247724,"spread":0.2835834167004996,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003963305,0.0002017647,0.000493026,0.0001896764,0.00004134953,0.00001458911,0.0001073185,0.0000593162,0.000003727444],"category_scores_gemma":[0.00007594092,0.0001468427,0.0000246551,0.0004109972,0.0003212221,0.0002182886,0.0000474203,0.0001227075,3.648991e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003188116,"about_ca_system_score_gemma":0.000162542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001656536,"about_ca_topic_score_gemma":0.00007568384,"domain_scores_codex":[0.9985165,0.000050751,0.0005256804,0.0003828238,0.0003281937,0.0001960716],"domain_scores_gemma":[0.9989567,0.00004621865,0.0002795378,0.0004913211,0.00007935438,0.0001468449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06194398,0.003026712,0.830806,0.000537837,0.0007217914,0.00008137382,0.005801695,0.0001477047,0.04135465,0.00001025419,0.0001154898,0.05545254],"study_design_scores_gemma":[0.02890602,0.004384837,0.9582225,0.0007811309,0.00009228617,0.00001024984,0.0008934552,0.0002532247,0.006108471,0.000009259245,0.000165596,0.0001729688],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983965,0.0002349265,0.00001042915,0.0001649233,0.00004082813,0.0010211,0.00006822914,0.00003884238,0.00002427321],"genre_scores_gemma":[0.9992679,0.0001461636,0.0002820269,0.00004066907,0.00001272378,0.000009784168,0.0001867886,0.00003081741,0.00002316188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1274165,"threshold_uncertainty_score":0.598807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308400784","doi":"10.1136/jitc-2022-sitc2022.1028","title":"1028 IL-12 and IL-27 upregulate CD39 expression on CD8<sup>+</sup> T-cells and differentially affect CD39<sup>+</sup>CD8<sup>+</sup> T-cell effector function","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Cytotoxic T cell; CD8; CD28; Biology; T cell; Molecular biology; IL-2 receptor; Tumor-infiltrating lymphocytes; Flow cytometry; Interleukin 21; Cancer research; Immune system; Cell biology; Chemistry; Immunology; In vitro; Biochemistry","authors":[{"name":"Lara Gerhardt","is_ca":true},{"name":"René Figueredo","is_ca":true},{"name":"Saman Maleki","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01338454817618056,"gpt":0.233697738298737,"spread":0.2203131901225564,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0009138109,0.001284852,0.001377697,0.0006822167,0.001184433,0.0004018551,0.0003449605,0.0004668061,0.0002397191],"category_scores_gemma":[0.0003567061,0.001120035,0.0003983155,0.0004695657,0.0007419256,0.0005239389,0.0006102758,0.001482572,0.0001166951],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003275863,"about_ca_system_score_gemma":0.0004302986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000179592,"about_ca_topic_score_gemma":0.000009411534,"domain_scores_codex":[0.9925383,0.0009159364,0.0009602425,0.002065578,0.00193989,0.001580109],"domain_scores_gemma":[0.9950315,0.0005296106,0.0003804007,0.001215199,0.0001544669,0.002688824],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007811361,0.003180199,0.03367142,0.003613657,0.001497127,0.002797081,0.003505814,0.01187159,0.8934772,0.0001440049,0.03083877,0.007591754],"study_design_scores_gemma":[0.04299467,0.02082916,0.1309927,0.003205625,0.003200772,0.002593105,0.002084889,0.03456129,0.7084825,0.001199368,0.04562728,0.004228672],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939314,0.0009523386,0.00003037664,0.0007822777,0.0003684525,0.002443896,0.0004494274,0.0003449575,0.0006968409],"genre_scores_gemma":[0.9929787,0.0004284444,0.0003354123,0.000633559,0.0004770512,0.000269081,0.0004307174,0.0002566187,0.004190417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1849947,"threshold_uncertainty_score":0.9999903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388047842","doi":"10.1136/jitc-2023-sitc2023.0544","title":"544 Coordinated blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector memory responses","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; EMD Serono","keywords":"Ovarian cancer; Cancer research; Immune system; Immunotherapy; Tumor microenvironment; Cytotoxic T cell; Cancer; Medicine; Immunology; Cytokine; Biology; Internal medicine","authors":[{"name":"Jacob Kment","is_ca":true},{"name":"Daniel Newsted","is_ca":true},{"name":"Stephanie Young","is_ca":true},{"name":"Michael Vermeulen","is_ca":true},{"name":"Andrew W. Craig","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03204473608297409,"gpt":0.3024263362297205,"spread":0.2703816001467464,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001986373,0.0003107874,0.0006877949,0.0001888696,0.0000985568,0.00004918307,0.0001127809,0.0003156693,0.0000152104],"category_scores_gemma":[0.0008508081,0.0002798152,0.0001002524,0.0004943354,0.0005626748,0.000171135,0.00006134126,0.0003670123,0.000001858607],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007643345,"about_ca_system_score_gemma":0.0003948285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001849043,"about_ca_topic_score_gemma":0.0001097179,"domain_scores_codex":[0.997479,0.0003133889,0.0007685315,0.0005828326,0.0003775142,0.0004787424],"domain_scores_gemma":[0.9985363,0.0003789343,0.000252895,0.0002893611,0.00008216357,0.0004603388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002364727,0.0002120925,0.03515669,0.0009215649,0.000335115,0.00009563248,0.001255182,0.00002265912,0.9479404,0.00001101581,0.004627244,0.007057646],"study_design_scores_gemma":[0.009934166,0.001056195,0.3155641,0.002595241,0.0003209619,0.0001647269,0.000382172,0.006811852,0.6600025,0.0004289583,0.001941008,0.0007981412],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990285,0.004279804,0.000004028162,0.003888209,0.0002454672,0.0008996901,0.0002030205,0.0001222221,0.00007250717],"genre_scores_gemma":[0.9979788,0.0007917645,0.0001031704,0.0001327195,0.00008401551,0.00007342497,0.0001008153,0.0000555738,0.0006797065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2879379,"threshold_uncertainty_score":0.9999654,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3113360743","doi":"10.1136/jitc-2020-sitc2020.0020","title":"20 Quantification of sBCMA in human plasma using a high-throughput mass spectrometry workflow for exploratory, CAP/CLIA or regulated studies","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Caprion (Canada)","funders":"","keywords":"Chemistry; Chromatography; Mass spectrometry; Peptide; Selected reaction monitoring; Tandem mass spectrometry; Biochemistry","authors":[{"name":"Luca Genovesi","is_ca":true},{"name":"Michael Schirm","is_ca":true},{"name":"Gwënaël Pottiez","is_ca":true},{"name":"Rudolf Guilbaud","is_ca":true},{"name":"Lorella Di Donato","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1380512454315843,"gpt":0.3556764921383321,"spread":0.2176252467067478,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003520825,0.0002914369,0.0007244137,0.0002270476,0.0001430823,0.00003875213,0.0001050944,0.0001685299,0.00001208435],"category_scores_gemma":[0.001092804,0.0002387362,0.00009987935,0.0005210178,0.0003500415,0.0002145109,0.00003732741,0.0002134252,0.000004509431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001648463,"about_ca_system_score_gemma":0.0003230532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001342007,"about_ca_topic_score_gemma":0.00008885083,"domain_scores_codex":[0.9978837,0.00008455177,0.0006096879,0.0005483413,0.0004248462,0.0004488707],"domain_scores_gemma":[0.9985036,0.0001179096,0.0002539056,0.0003200735,0.0002078882,0.0005966774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001552856,0.000279836,0.04846594,0.001794562,0.0008222542,0.0003876462,0.001703516,0.0003532628,0.9420641,0.00042209,0.001541087,0.0006128204],"study_design_scores_gemma":[0.01211036,0.0018383,0.1539305,0.001544453,0.0004674113,0.00008560426,0.002504723,0.008156667,0.8167805,0.001472295,0.0005062881,0.00060295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995715,0.0009142217,0.0001909032,0.001888975,0.0001154826,0.001032038,0.00006079688,0.00006062076,0.00002193541],"genre_scores_gemma":[0.9826815,0.0001189357,0.01656069,0.00009684407,0.000158042,0.00005511829,0.00013352,0.00005028461,0.000145038],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1252836,"threshold_uncertainty_score":0.9735382,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3113081454","doi":"10.1136/jitc-2020-sitc2020.0265","title":"265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Interim analysis; Interim; Avelumab; Cohort; Urothelial carcinoma; Oncology; Medicine; Internal medicine; Political science; Bladder cancer; Immunotherapy; Cancer; Clinical trial","authors":[{"name":"Jean‐Laurent Deville","is_ca":false},{"name":"Alain Ravaud","is_ca":false},{"name":"Marco Maruzzo","is_ca":false},{"name":"Theodore Stewart Gourdin","is_ca":false},{"name":"Michele Maio","is_ca":false},{"name":"Luc Dirix","is_ca":false},{"name":"XiaoZhe Wang","is_ca":false},{"name":"Yulia Vugmeyster","is_ca":false},{"name":"Frank Beier","is_ca":false},{"name":"Jeorg Seebeck","is_ca":false},{"name":"Sarah Chennoufi","is_ca":false},{"name":"James L. Gulley","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01670594694064256,"gpt":0.2663233916641324,"spread":0.2496174447234899,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003136614,0.000360353,0.0009902021,0.0002460367,0.00007656832,0.00003887249,0.0001536216,0.0001259465,0.00001870528],"category_scores_gemma":[0.0002500492,0.0002922573,0.0001538005,0.000750408,0.0002373861,0.000193985,0.00006086635,0.0002802466,0.000002300347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001065686,"about_ca_system_score_gemma":0.0003085364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002439326,"about_ca_topic_score_gemma":0.0003500867,"domain_scores_codex":[0.9971055,0.0001089705,0.001033263,0.0007649749,0.0006354692,0.0003518118],"domain_scores_gemma":[0.9983116,0.00005003638,0.0004537387,0.0005149146,0.0001571405,0.0005125636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03773657,0.003505668,0.9098084,0.0001237751,0.001894062,0.0002474857,0.00988936,0.0002405701,0.03396284,0.000001090524,0.0001825813,0.00240762],"study_design_scores_gemma":[0.04452669,0.005237709,0.930797,0.0003007904,0.0009025662,0.000004270047,0.001438563,0.0003957526,0.01597909,0.000005329116,0.00009615445,0.0003160339],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977409,0.0001554603,0.00001283404,0.0003776592,0.00009410585,0.001261387,0.000250051,0.00004686935,0.00006074279],"genre_scores_gemma":[0.9987627,0.00002574777,0.0003264971,0.0003689391,0.00008294857,0.00003122158,0.0003383622,0.0000422751,0.00002126458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02098866,"threshold_uncertainty_score":0.999953,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048048","doi":"10.1136/jitc-2023-sitc2023.0582","title":"582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Tumor microenvironment; Breast cancer; Immune system; Oncology; Internal medicine; Antibody; Triple-negative breast cancer; Cancer; Cancer research; Immunotherapy; Immunology; Nivolumab","authors":[{"name":"Julian Olea","is_ca":false},{"name":"Homa Dadrastoussi","is_ca":false},{"name":"Eduardo Fernandez Hernandez","is_ca":false},{"name":"Hugo Lara Martinez","is_ca":false},{"name":"Kaijin Wu","is_ca":false},{"name":"Houra Loghmani","is_ca":true},{"name":"Thomas Heineman","is_ca":false},{"name":"Richard Trauger","is_ca":false},{"name":"Matt Coffey","is_ca":true},{"name":"Fernando Salvador","is_ca":false},{"name":"Joaquín Gavilá","is_ca":false},{"name":"Tomás Pascual","is_ca":false},{"name":"Luís Manso","is_ca":false},{"name":"Aleix Prat","is_ca":false},{"name":"Akil Merchant","is_ca":false},{"name":"Kevin R. Kelly","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01259663640010753,"gpt":0.2596904684011493,"spread":0.2470938320010418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003586474,0.0002251243,0.0003026889,0.00008894414,0.0002913029,0.00009053859,0.0001972935,0.00006288478,0.000002966847],"category_scores_gemma":[0.0000917712,0.0001405637,0.000189543,0.0004543876,0.0003439999,0.00001709086,0.0001918184,0.0001374716,5.187068e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007127908,"about_ca_system_score_gemma":0.0002253349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00569219,"about_ca_topic_score_gemma":0.0004533407,"domain_scores_codex":[0.9983355,0.0001046207,0.0003417491,0.0004960902,0.000368638,0.0003533636],"domain_scores_gemma":[0.9990007,0.00004070676,0.0002300315,0.0005067268,0.00003514029,0.0001866487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003832481,0.00006469692,0.2510486,0.00004050268,0.003604718,0.0000996309,0.0005095042,0.001476665,0.7377766,0.000002642101,0.0001823668,0.001361553],"study_design_scores_gemma":[0.01076793,0.0001153539,0.8330517,0.0002323211,0.001615397,0.00004801295,0.0006364499,0.001415159,0.1514258,0.00003251537,0.000336132,0.0003232258],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966893,0.001580291,0.00003040834,0.0006301402,0.0001185302,0.0003642925,0.000561504,0.00001149661,0.00001399621],"genre_scores_gemma":[0.9991391,0.0002860194,0.0001191089,0.00007258348,0.0001096385,0.00002105954,0.0001701121,0.00002901904,0.00005332417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5863509,"threshold_uncertainty_score":0.8604927,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388047658","doi":"10.1136/jitc-2023-sitc2023.0654","title":"654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cytokine release syndrome; Chimeric antigen receptor; Adverse effect; Refractory (planetary science); Internal medicine; Pharmacokinetics; Immunotherapy; Leukapheresis; T cell; Chemotherapy; Oncology; Gastroenterology; Immunology; Immune system; Cancer; Stem cell","authors":[{"name":"Daniel J. Olson","is_ca":false},{"name":"Ecaterina E. Dumbrava","is_ca":false},{"name":"Mridula George","is_ca":false},{"name":"Sam Saibil","is_ca":true},{"name":"Marcus O. Butler","is_ca":true},{"name":"Antonio Giordano","is_ca":false},{"name":"Brooke Pieke","is_ca":false},{"name":"Miriam Gavriliuc","is_ca":false},{"name":"Emily Lichtenstein","is_ca":false},{"name":"Jill Geisberger","is_ca":true},{"name":"Maria Apostolopoulou","is_ca":false},{"name":"Kara Moss","is_ca":false},{"name":"D’Arcy Kirkwood","is_ca":false},{"name":"Salina Dang","is_ca":false},{"name":"Deyaa Adib","is_ca":false},{"name":"Benjamin L. Schlechter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0445197377225094,"gpt":0.3424634879703385,"spread":0.2979437502478291,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001835756,0.0003743157,0.001030225,0.0005294405,0.0002123233,0.00004633125,0.0001640491,0.0003443412,0.0001013699],"category_scores_gemma":[0.00469926,0.0003199749,0.0001295892,0.0009076882,0.001008247,0.0001480388,0.0001672398,0.0007873501,0.00001136305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001430145,"about_ca_system_score_gemma":0.001132015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003167174,"about_ca_topic_score_gemma":0.00007595139,"domain_scores_codex":[0.9965336,0.0002393063,0.001157016,0.0006746845,0.0006897729,0.0007055704],"domain_scores_gemma":[0.9974751,0.0004954999,0.0003426666,0.000541065,0.0001111911,0.001034419],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.05092726,0.001594115,0.006823482,0.001395618,0.0004253656,0.002434578,0.008551176,0.0001769192,0.8870169,0.0002886983,0.003004858,0.03736106],"study_design_scores_gemma":[0.4184484,0.02644029,0.3066423,0.005346483,0.0005979381,0.001908533,0.003313212,0.007852544,0.196765,0.001781893,0.02870267,0.002200749],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995786,0.0003389056,0.00000137229,0.001388828,0.0002423046,0.001318156,0.0000280992,0.0001841743,0.0007122254],"genre_scores_gemma":[0.9954566,0.0003104564,0.0004438176,0.0002309105,0.0002621143,0.0000393189,0.00007460593,0.00008337687,0.003098849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6902519,"threshold_uncertainty_score":0.9999253,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388071235","doi":"10.1136/jitc-2023-sitc2023.1490","title":"1490 High-plex co-detection of RNA and protein to explore tumor-immune interactions utilizing RNAscope with imaging mass cytometry","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; RNA; Biology; Molecular biology; Computational biology; Phenotype; Biochemistry","authors":[{"name":"James Pemberton","is_ca":true},{"name":"Smriti Kala","is_ca":true},{"name":"Anushka Dikshit","is_ca":false},{"name":"Clinton Hupple","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01845165894724315,"gpt":0.2781303994629118,"spread":0.2596787405156686,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001627234,0.0001747355,0.0001755184,0.0001345054,0.0001614803,0.00004569298,0.00008337243,0.00005771551,8.839414e-7],"category_scores_gemma":[0.0001102446,0.0001621076,0.00003555038,0.0002823254,0.0001910356,0.00002126384,0.00007292729,0.0001241199,0.000002803973],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001670535,"about_ca_system_score_gemma":0.00004738222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006475546,"about_ca_topic_score_gemma":0.00001170875,"domain_scores_codex":[0.9990134,0.00002203428,0.0002498193,0.0003654568,0.0001295745,0.0002196901],"domain_scores_gemma":[0.9992592,0.000009889165,0.0001408978,0.0002971136,0.00009217974,0.0002006612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003482036,0.00001248916,0.0004043077,0.00004603395,0.00002212339,0.00000747654,0.00004885203,0.00003332374,0.9978775,0.00005915844,0.0001763447,0.001277504],"study_design_scores_gemma":[0.0002074157,0.0001223904,0.01111635,0.0001499253,0.00001869115,0.00006782868,0.0003602262,0.0000704601,0.9821001,0.0003593121,0.005229033,0.0001982777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948221,0.0001463402,0.003932912,0.0004425555,0.00004132062,0.0003753429,0.00001915864,0.00009682955,0.000123416],"genre_scores_gemma":[0.9917896,0.00005550801,0.007683929,0.00008490077,0.00007130112,0.00006195944,0.00006163844,0.00003573499,0.0001554493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01577747,"threshold_uncertainty_score":0.6610556,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3214232282","doi":"10.1136/jitc-2021-sitc2021.353","title":"353 Identification of potential response predictors to maveropepimut-S (DPX-Survivac), a novel T cell activating immunotherapy, in patients with advanced recurrent ovarian cancer","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Alberta Health Services; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunotherapy; CD8; Immune system; T cell; Antigen; Ovarian cancer; Oncology; Immunohistochemistry; Cancer research; Cancer; Cyclophosphamide; Internal medicine; Chemotherapy; Immunology","authors":[{"name":"Oliver Dorigo","is_ca":false},{"name":"Walead Ebrahimizadeh","is_ca":false},{"name":"Barry Kennedy","is_ca":false},{"name":"Lisa D. MacDonald","is_ca":false},{"name":"Stephan Fiset","is_ca":false},{"name":"Jeannine Villella","is_ca":false},{"name":"O D L U Z H N E V S K A Y A","is_ca":true},{"name":"Tanja Pejović","is_ca":false},{"name":"Prafull Ghatage","is_ca":true},{"name":"Diane Provencher","is_ca":false},{"name":"Yogesh Bramhecha","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00683929153160976,"gpt":0.2201043896604499,"spread":0.2132650981288401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006466656,0.0003154074,0.0004585847,0.0002214636,0.0001826967,0.00004790386,0.0002176704,0.0002408558,0.00005404526],"category_scores_gemma":[0.0003596908,0.0002898613,0.00008526142,0.0004022197,0.0002309597,0.0002752118,0.00007777534,0.0003391329,0.000009367935],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001123302,"about_ca_system_score_gemma":0.0004897267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001851557,"about_ca_topic_score_gemma":0.00002406998,"domain_scores_codex":[0.9976762,0.0004318014,0.0007746759,0.0005224865,0.0001609288,0.0004339092],"domain_scores_gemma":[0.9986169,0.0001202558,0.0004275461,0.0004854989,0.0002642819,0.0000854934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.007805084,0.000436645,0.01924133,0.00005250432,0.0001796429,0.00000712556,0.001446822,0.0003138979,0.9663523,0.0000262431,0.00005191809,0.004086527],"study_design_scores_gemma":[0.003143394,0.0002753419,0.5042745,0.0002001598,0.00002088719,0.00001204498,0.0001964344,0.000003121664,0.4896416,0.000007240773,0.002012001,0.0002132257],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956045,0.002448644,0.0001629173,0.0003228643,0.000761165,0.0005045776,0.0001320163,0.00003765391,0.00002567587],"genre_scores_gemma":[0.9983721,0.0002174253,0.0003912189,0.0001200058,0.0000163538,0.0000536991,0.0001121884,0.00004833276,0.0006686443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4850332,"threshold_uncertainty_score":0.9999554,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4416074415","doi":"10.1136/jitc-2025-sitc2025.0106","title":"106 Spatial multi-omic characterization of tumor microenvironment heterogeneity in hepatocellular carcinoma","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Tumor microenvironment; Hepatocellular carcinoma; Tumor heterogeneity; Tumor cells; Cancer","authors":[{"name":"Atefeh Khakpoor","is_ca":false},{"name":"Qanber Raza","is_ca":true},{"name":"Dina Kazemi","is_ca":false},{"name":"Erin Coll","is_ca":false},{"name":"Liang Lim","is_ca":true},{"name":"Nick Zabinyakov","is_ca":false},{"name":"Liang Qiao","is_ca":false},{"name":"Anna Di Bartolomeo","is_ca":false},{"name":"Helen M. McGuire","is_ca":false},{"name":"Jacob George","is_ca":false},{"name":"Ankur Sharma","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02886582805946386,"gpt":0.2299068720586562,"spread":0.2010410439991923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007882684,0.000884812,0.001455878,0.0006388631,0.0002004759,0.00009450199,0.0002690016,0.000526481,0.00005593591],"category_scores_gemma":[0.0002104713,0.000928023,0.0003983512,0.0004993436,0.0007815913,0.0002564702,0.0002236905,0.0005552667,0.00003458976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004738703,"about_ca_system_score_gemma":0.000867811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001938043,"about_ca_topic_score_gemma":0.0001585288,"domain_scores_codex":[0.9950463,0.0003868198,0.00186194,0.001225628,0.0005553133,0.0009239549],"domain_scores_gemma":[0.9974268,0.00006543836,0.0006712344,0.00086476,0.000114259,0.0008574806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001891494,0.0006581891,0.6362301,0.001290414,0.0002180531,0.0004726499,0.0003980405,0.000003692556,0.3595004,0.00002830942,0.0000263116,0.0009847156],"study_design_scores_gemma":[0.003204127,0.0002198786,0.5613929,0.0009236464,0.0006696105,0.00004758384,0.00006247029,0.008320116,0.4240521,0.00002230974,0.0007164371,0.000368849],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892085,0.00608604,0.0002201889,0.001049273,0.0008338826,0.002289573,0.0001877974,0.00004240673,0.00008235273],"genre_scores_gemma":[0.996855,0.0009888512,0.0004233468,0.0004311044,0.0001602012,0.0001099886,0.0004586837,0.0000859032,0.0004868988],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07483722,"threshold_uncertainty_score":0.999317,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048122","doi":"10.1136/jitc-2023-sitc2023.0738","title":"738 A phase 1/2 study investigating the safety and efficacy of autologous TAC T cells in subjects with unresectable, locally advanced or metastatic claudin 18.2+ solid tumors","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Immunotherapy; Leukapheresis; Chimeric antigen receptor; Cancer research; Radioimmunotherapy; Stem cell; Immunology; Immune system; Antibody; Biology; CD34","authors":[{"name":"Daniel J. Olson","is_ca":false},{"name":"Ecaterina E. Dumbrava","is_ca":false},{"name":"Sam Saibil","is_ca":true},{"name":"Martin Gutierez","is_ca":false},{"name":"Syma Iqbal","is_ca":false},{"name":"Davendra Sohal","is_ca":false},{"name":"Maria Apostolopoulou","is_ca":false},{"name":"Kara Moss","is_ca":false},{"name":"Deyaa Adib","is_ca":false},{"name":"Benjamin L. Schlechter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03770694743003553,"gpt":0.3355257030615537,"spread":0.2978187556315182,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002041772,0.0004108984,0.0009763315,0.0003828414,0.0002126688,0.00008318114,0.0002308592,0.0001043938,0.00004790397],"category_scores_gemma":[0.001614679,0.0002626461,0.0000690786,0.001485324,0.001090909,0.0001780598,0.0001539515,0.0006824899,0.000006316081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009888117,"about_ca_system_score_gemma":0.001113012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004576085,"about_ca_topic_score_gemma":0.000503426,"domain_scores_codex":[0.9964299,0.0003753909,0.0008788905,0.0006734633,0.0008954315,0.0007469478],"domain_scores_gemma":[0.997381,0.0008275042,0.0003079897,0.0005996316,0.0001586405,0.000725251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01192709,0.002012002,0.05844419,0.002160862,0.001133971,0.00578228,0.01707678,0.005434507,0.8771251,0.000104336,0.0008354047,0.01796343],"study_design_scores_gemma":[0.06163951,0.01445329,0.5757089,0.003584063,0.000822011,0.001690635,0.01784089,0.009871161,0.3112108,0.0005685849,0.001254307,0.001355875],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959896,0.0003342935,0.0000104983,0.0007246959,0.00007089147,0.002488943,0.00002544438,0.0001133051,0.0002423486],"genre_scores_gemma":[0.9976622,0.0001898455,0.0006498887,0.0001937881,0.00004755546,0.00008007931,0.00002653606,0.00008085569,0.001069217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5659144,"threshold_uncertainty_score":0.9999826,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308378595","doi":"10.1136/jitc-2022-sitc2022.0052","title":"52 Digital pathology training effectiveness for the evaluation of PD-L1 expression in multiple tumor indications","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Digital pathology; Concordance; Medicine; Digital image analysis; Test (biology); Medical physics; Artificial intelligence; Computer science; Pathology; Computer vision; Internal medicine","authors":[{"name":"Jennifer G. Robinson","is_ca":false},{"name":"Edward Manna","is_ca":false},{"name":"Charlotte Roach","is_ca":false},{"name":"Ryan Marczak","is_ca":false},{"name":"Arkendra De","is_ca":false},{"name":"Joshua Littrell","is_ca":false},{"name":"Micki Adams","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04122079206106776,"gpt":0.3111353124665198,"spread":0.2699145204054521,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002563008,0.0001047931,0.0002368392,0.0001174747,0.0002327006,0.00002131742,0.00009321195,0.00003965572,0.000009777903],"category_scores_gemma":[0.003969391,0.00008114587,0.00006439478,0.0001463731,0.0002338135,0.00008292159,0.00005592275,0.0003258371,3.747694e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007670996,"about_ca_system_score_gemma":0.0003287919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002478212,"about_ca_topic_score_gemma":0.000002924384,"domain_scores_codex":[0.9986905,0.0001883869,0.0002940667,0.0002350182,0.0004097863,0.0001822378],"domain_scores_gemma":[0.9988901,0.0005387266,0.0001687382,0.0001864599,0.00007402511,0.000141953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0006400843,0.0006165301,0.411416,0.000736826,0.0001845423,0.000103073,0.01111944,0.02573324,0.4573691,0.0008582048,0.0008065992,0.09041639],"study_design_scores_gemma":[0.003708653,0.0002065409,0.9216999,0.0002655511,0.0001721227,0.0003405652,0.001620122,0.05809037,0.009514578,0.00239805,0.001835235,0.0001483588],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996677,0.0005454302,0.0006737791,0.0009607605,0.0002014358,0.0008017661,0.00002438639,0.0000192719,0.00009620954],"genre_scores_gemma":[0.9986697,0.000009114213,0.0006797413,0.0001731532,0.00006056416,0.0002982336,0.00007408601,0.0000195187,0.00001589371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5102839,"threshold_uncertainty_score":0.4752019,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388072202","doi":"10.1136/jitc-2023-sitc2023.0594","title":"594 SQZ-PBMC-HPV-101: Increased overall survival in a subset of patients with recurrent, locally advanced, or metastatic HPV16<sup>+</sup>tumors treated with cell-based vaccine, SQZ-PBMC-HPV","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Peripheral blood mononuclear cell; Medicine; Antigen; CD8; T cell; Immunotherapy; Immunology; Immune system; Internal medicine; Oncology; Biology","authors":[{"name":"Antonio Jimeno","is_ca":false},{"name":"Wade T. Iams","is_ca":false},{"name":"Jong‐Chul Park","is_ca":false},{"name":"Udo Holtick","is_ca":false},{"name":"Michael S. Gordon","is_ca":false},{"name":"Kerry J. Rodabaugh","is_ca":false},{"name":"Neesha C. Dhani","is_ca":true},{"name":"Matthew H. Taylor","is_ca":false},{"name":"Eric Duvall","is_ca":false},{"name":"Julia Jennings","is_ca":false},{"name":"Nathan R. Miselis","is_ca":false},{"name":"Scott Loughhead","is_ca":false},{"name":"Marshelle Warren","is_ca":false},{"name":"Howard Bernstein","is_ca":false},{"name":"Joaquina Baranda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01966662828364165,"gpt":0.2677507664605239,"spread":0.2480841381768823,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007466695,0.0006923409,0.001341503,0.0006405924,0.0001502196,0.00007909833,0.0002855237,0.0001949345,0.0004061848],"category_scores_gemma":[0.00045677,0.0004821669,0.0001573844,0.001692666,0.0003981271,0.0003108646,0.00008651106,0.0007072225,0.0000244654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002482826,"about_ca_system_score_gemma":0.001734082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001687206,"about_ca_topic_score_gemma":0.001260584,"domain_scores_codex":[0.9951466,0.0002754193,0.0009987582,0.0009790233,0.001529276,0.001070897],"domain_scores_gemma":[0.9965919,0.0002991874,0.0003482084,0.0007423672,0.0005891385,0.001429248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03185096,0.002119757,0.9398178,0.004127811,0.0005150812,0.002020761,0.0007726182,0.008289513,0.001145965,0.0000609832,0.003844631,0.005434086],"study_design_scores_gemma":[0.02430778,0.003698589,0.9589711,0.0005419242,0.0003736695,0.00003603965,0.0004040867,0.004306855,0.005866718,0.00009307818,0.0007014723,0.0006986834],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958803,0.0002410747,0.00002804884,0.0003764927,0.00005646048,0.001703189,0.0003381264,0.0001644569,0.001211841],"genre_scores_gemma":[0.9966936,0.00008548678,0.0007613398,0.0002715005,0.00006550597,0.0001301193,0.001446255,0.0001398952,0.0004062959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01915327,"threshold_uncertainty_score":0.999763,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404064412","doi":"10.1136/jitc-2024-sitc2024.0361","title":"361 Early differentiation and memory transcription programs drive long-term persistence of NY-ESO-1 specific TCR-T cells in adoptive cell therapy","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"T-cell receptor; Term (time); Persistence (discontinuity); Biology; Computer science; T cell; Immunology; Physics; Engineering; Immune system","authors":[{"name":"Marcus O Butler","is_ca":true},{"name":"Valentin Sotov","is_ca":true},{"name":"Dong-Hoon Han","is_ca":true},{"name":"Sam Saibil","is_ca":true},{"name":"Sarah Boross-Harmer","is_ca":true},{"name":"Linh T. Nguyen","is_ca":true},{"name":"Elizabeth Scheid","is_ca":true},{"name":"Dalam Ly","is_ca":true},{"name":"Sawako Elston","is_ca":true},{"name":"Meng Xu","is_ca":true},{"name":"Pamela S. Ohashi","is_ca":true},{"name":"Shinya Tanaka","is_ca":false},{"name":"Naoto Hirano","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.035798880816205,"gpt":0.2570067381479863,"spread":0.2212078573317813,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003801049,0.0002655504,0.0003938937,0.0002726052,0.00005855197,0.0001376898,0.000090128,0.0002010807,0.00007317883],"category_scores_gemma":[0.0000123367,0.0002327259,0.0001332966,0.0002982597,0.0004840721,0.0002439378,0.00002162613,0.0004250044,0.000006976074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001070371,"about_ca_system_score_gemma":0.0001617193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009978317,"about_ca_topic_score_gemma":0.00003116663,"domain_scores_codex":[0.998096,0.00009960517,0.0004108941,0.0005312538,0.0005106236,0.0003515978],"domain_scores_gemma":[0.999118,0.00004823495,0.000085045,0.0002642368,0.000101426,0.0003830425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002598614,0.0002161864,0.03855373,0.0006606425,0.00008994786,0.0001468664,0.006412554,0.000004516321,0.9325042,0.00003331924,0.00005861132,0.0210596],"study_design_scores_gemma":[0.001511013,0.0006850557,0.5453105,0.0006648677,0.00006741556,0.00005901042,0.0005585801,0.0001611767,0.4502512,0.0001090159,0.0003971717,0.0002250275],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905348,0.007448252,0.00002749851,0.000264991,0.0002446212,0.0009907808,0.00001291048,0.00006136577,0.0004147939],"genre_scores_gemma":[0.9948377,0.003194623,0.0002157526,0.00003220604,0.0001238376,0.00003047282,0.00005715631,0.00004718304,0.001461097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5067567,"threshold_uncertainty_score":0.9490288,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404065332","doi":"10.1136/jitc-2024-sitc2024.0878","title":"878 The immunomodulatory impact of chemotherapy when combined with PD-1 blockade in resectable lung cancers","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Blockade; Medicine; Chemotherapy; Lung; Oncology; Internal medicine; Cancer research; Receptor","authors":[{"name":"Sydney Connor","is_ca":false},{"name":"Jiajia Zhang","is_ca":false},{"name":"Khaled Sanber","is_ca":false},{"name":"Tianbei Zhang","is_ca":false},{"name":"Roni Rayes","is_ca":true},{"name":"Rulin Wang","is_ca":false},{"name":"Zhicheng Ji","is_ca":false},{"name":"Isha Gurumurthy","is_ca":false},{"name":"Dipika Singh","is_ca":false},{"name":"Julie S. Deutsch","is_ca":false},{"name":"Janis M. Taube","is_ca":false},{"name":"Srinivasan Yegnasubramanian","is_ca":false},{"name":"J. Spicer","is_ca":true},{"name":"Patrick F. Forde","is_ca":false},{"name":"Hongkai Ji","is_ca":false},{"name":"Drew M. Pardoll","is_ca":false},{"name":"Kellie N. Smith","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009662269831908502,"gpt":0.2611179576055441,"spread":0.2514556877736356,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005405844,0.0002670804,0.0004120058,0.0001684498,0.00007797337,0.00007285511,0.0001344354,0.0001353857,0.00006598151],"category_scores_gemma":[0.00003724237,0.0001601411,0.0001688197,0.0003788017,0.0004923165,0.0001600389,0.00002041029,0.0003490206,0.000001765895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004408092,"about_ca_system_score_gemma":0.001415173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004796182,"about_ca_topic_score_gemma":0.000314445,"domain_scores_codex":[0.9985015,0.00005162604,0.0004070488,0.0003412623,0.0003382237,0.0003603839],"domain_scores_gemma":[0.9991367,0.00006421341,0.0001059456,0.0004239327,0.0000583847,0.0002107848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01519302,0.0003057372,0.2311646,0.002133165,0.004499128,0.000499393,0.01328262,0.0008453207,0.6979285,0.000315176,0.02739093,0.006442318],"study_design_scores_gemma":[0.006326087,0.001697069,0.9012707,0.002319674,0.0002506933,0.0004616252,0.0005472015,0.002129728,0.076905,0.0005319234,0.007059393,0.0005009191],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836194,0.01302637,0.000004514209,0.001949811,0.0001824466,0.0005570796,0.00001787358,0.00006064574,0.0005818856],"genre_scores_gemma":[0.9980425,0.0006459606,0.0001328915,0.0002811856,0.00009671856,0.00003022683,0.00001570628,0.0000513612,0.0007034995],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6701061,"threshold_uncertainty_score":0.7250424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415899279","doi":"10.1136/jitc-2025-sitc2025.1036","title":"1036 KAN-004, a metabolically complete live biotherapeutic product for the treatment of immune-related colitis","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Product (mathematics); Colitis; Ulcerative colitis; Inflammatory bowel disease; Inflammation","authors":[{"name":"James E. Berleman","is_ca":false},{"name":"Lee R. Swem","is_ca":false},{"name":"Kyle Jacoby","is_ca":false},{"name":"Peter J Diebold","is_ca":false},{"name":"K. Robertson","is_ca":false},{"name":"Aditya Bhalla","is_ca":false},{"name":"Jackson Mintz","is_ca":false},{"name":"Pallavi Murugkar","is_ca":false},{"name":"Hannah Bronson","is_ca":false},{"name":"Meriem Messaoudene","is_ca":false},{"name":"Anna Pérez","is_ca":false},{"name":"Wiam Belkaïd","is_ca":false},{"name":"Marguerite Prior","is_ca":false},{"name":"Philip Burnham","is_ca":false},{"name":"Hao Shi","is_ca":false},{"name":"Mark Weinberg","is_ca":false},{"name":"Bertrand Routy","is_ca":true},{"name":"Arielle Elkrief","is_ca":false},{"name":"Matthew P. Cheng","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0124908853177363,"gpt":0.2491996479293751,"spread":0.2367087626116388,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005474035,0.0006750918,0.0007593436,0.0001196898,0.000476476,0.0001315996,0.0004177261,0.0004193242,0.0000219281],"category_scores_gemma":[0.0003830211,0.000538043,0.0006795985,0.0002204569,0.00155512,0.0000174381,0.00009647609,0.0001627934,0.000008806318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009427287,"about_ca_system_score_gemma":0.001471969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001869018,"about_ca_topic_score_gemma":0.0001150831,"domain_scores_codex":[0.9965187,0.0002534186,0.001285627,0.0009590898,0.0002684889,0.000714634],"domain_scores_gemma":[0.9972308,0.0001160238,0.0005817111,0.001209222,0.0004093461,0.000452951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.005158091,0.002793212,0.01683661,0.00333534,0.01696484,0.0001714946,0.003484252,0.001074151,0.9008814,0.0123436,0.003903763,0.03305327],"study_design_scores_gemma":[0.0061604,0.001095794,0.4578876,0.0004198824,0.003445481,0.00006292839,0.0003530285,0.0009152238,0.2311629,0.00175461,0.2957513,0.0009909143],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9294002,0.06221639,0.00007689319,0.002950909,0.001112954,0.003203899,0.0006696767,0.00003109212,0.0003380076],"genre_scores_gemma":[0.9907452,0.005077736,0.0003668084,0.0004338968,0.0002609978,0.0002868107,0.0002082141,0.0000715432,0.002548805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6697185,"threshold_uncertainty_score":0.9997071,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415898701","doi":"10.1136/jitc-2025-sitc2025.0078","title":"78 Exploratory radiomics analysis in unresectable hepatocellular carcinoma treated with durvalumab alone or combined with tremelimumab or bevacizumab","year":2025,"lang":"","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Tremelimumab; Bevacizumab; Radiomics; Hepatocellular carcinoma; Nivolumab; Exploratory analysis","authors":[{"name":"Hanif Gabrani-Juma","is_ca":true},{"name":"Qin Li","is_ca":false},{"name":"Young S. Lee","is_ca":false},{"name":"Patricia McCoon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01516017579874371,"gpt":0.250318711045627,"spread":0.2351585352468833,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00200283,0.001425631,0.003252899,0.002146346,0.0006153787,0.0004559786,0.0005662038,0.0006763996,0.0001474966],"category_scores_gemma":[0.001560309,0.0009807748,0.000324448,0.005790945,0.001804305,0.0005831122,0.0001852841,0.001991739,0.00001194751],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008982941,"about_ca_system_score_gemma":0.004891239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00318581,"about_ca_topic_score_gemma":0.002000972,"domain_scores_codex":[0.9921302,0.0007010204,0.002021897,0.002019808,0.001383391,0.001743682],"domain_scores_gemma":[0.9946727,0.0005004993,0.000773354,0.001558949,0.0004316972,0.002062767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02437065,0.001274905,0.9364918,0.002375175,0.007231806,0.01362371,0.00243241,0.004127275,0.004501151,0.0002588159,0.001518864,0.00179339],"study_design_scores_gemma":[0.07492948,0.00848369,0.5204079,0.008555257,0.02454886,0.001574679,0.005911015,0.3225278,0.02410229,0.0002239708,0.005167169,0.003567945],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886281,0.004419335,0.0005799478,0.003335073,0.0003119774,0.001833581,0.00004819574,0.0001880941,0.0006556332],"genre_scores_gemma":[0.9898199,0.001259023,0.00193381,0.001078833,0.0001919578,0.0001084696,0.0002996103,0.0001995565,0.005108861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.416084,"threshold_uncertainty_score":0.9998494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404052940","doi":"10.1136/jitc-2024-sitc2024.0103","title":"103 A deep-learning approach to guide acquisition region selection for Imaging Mass Cytometry","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Mass cytometry; Computer science; Selection (genetic algorithm); Artificial intelligence; Deep learning; Machine learning; Chemistry","authors":[{"name":"F. R. N. Schneider","is_ca":false},{"name":"Smriti Kala","is_ca":false},{"name":"Clinton Hupple","is_ca":true},{"name":"James Mansfield","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01268774742898928,"gpt":0.2480845245117705,"spread":0.2353967770827812,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007130504,0.0002359111,0.000194158,0.0004042668,0.0003227218,0.0007462918,0.0002647192,0.0001233374,9.692936e-7],"category_scores_gemma":[0.0001917074,0.0002460839,0.00009663837,0.0008583129,0.00006438827,0.001001611,0.00007959231,0.0002702036,0.00001902001],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003533429,"about_ca_system_score_gemma":0.0001676906,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005973266,"about_ca_topic_score_gemma":0.000003446847,"domain_scores_codex":[0.9980224,0.0000740316,0.0003425097,0.0008065835,0.000340735,0.0004137808],"domain_scores_gemma":[0.9990528,0.0000717856,0.00009711731,0.0002713868,0.0001305509,0.0003763507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.00018955,0.000172396,0.01155147,0.003205257,0.0004441338,0.0001444686,0.008532709,0.04746515,0.4637196,0.04162877,0.06483062,0.3581159],"study_design_scores_gemma":[0.0004381286,0.0002275855,0.007816968,0.0003946707,0.00007706726,0.00101932,0.0002016631,0.8463171,0.04814537,0.00960466,0.08499008,0.0007673678],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.02420487,0.000912848,0.9700344,0.001500353,0.0009597178,0.0004458663,0.000001802113,0.000750934,0.001189232],"genre_scores_gemma":[0.8793749,0.00003528844,0.1188252,0.00044265,0.0005038738,0.0001349583,0.00001359622,0.00004650173,0.0006229662],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.8551701,"threshold_uncertainty_score":0.9999992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042528","doi":"10.1136/jitc-2023-sitc2023.0689","title":"689 Pharmacodynamic results with talquetamab and daratumumab in patients with relapsed/refractory multiple myeloma in TRIMM-2","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; CD38; Pharmacodynamics; Internal medicine; Multiple myeloma; CD8; Oncology; Refractory (planetary science); Antibody; Monoclonal antibody; Pharmacology; Immunology; Gastroenterology; Bortezomib; Immune system; Pharmacokinetics; Stem cell; Biology; CD34","authors":[{"name":"Deeksha Vishwamitra","is_ca":false},{"name":"Sheri Skerget","is_ca":false},{"name":"M. Damiette Smit","is_ca":false},{"name":"Lien Vandenberk","is_ca":false},{"name":"Kalpana Bakshi","is_ca":false},{"name":"Sangmin Lee","is_ca":false},{"name":"Bhagirathbhai Dholaria","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Niels WCJ van de Donk","is_ca":false},{"name":"Raluca Verona","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01426746225719454,"gpt":0.255296573393422,"spread":0.2410291111362274,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006965243,0.0003509132,0.0005334322,0.0005808095,0.00009901918,0.00006509749,0.0001119903,0.0001950583,0.0000155455],"category_scores_gemma":[0.0003450854,0.0002753671,0.00004023201,0.0008645481,0.0004628356,0.0002946041,0.00006913094,0.0007346494,0.00001515691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001990949,"about_ca_system_score_gemma":0.0003749583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004202611,"about_ca_topic_score_gemma":0.0006004384,"domain_scores_codex":[0.9973047,0.0001214456,0.0005211228,0.0007027955,0.0007097589,0.0006401205],"domain_scores_gemma":[0.9985483,0.0001573104,0.0001418722,0.000418294,0.0001069756,0.000627241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01052664,0.0004956867,0.9368231,0.0004029242,0.0001662675,0.001417916,0.001733656,0.0001885867,0.04001673,0.00001546938,0.001148754,0.007064295],"study_design_scores_gemma":[0.02462733,0.0009638788,0.9647894,0.0005794489,0.0000445674,0.00007081065,0.0002045868,0.0009034181,0.004388939,0.0000341611,0.003049015,0.0003444461],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968324,0.0002666258,7.53477e-7,0.000617281,0.00008523347,0.001035443,0.00004801195,0.0001077086,0.001006508],"genre_scores_gemma":[0.9974151,0.0002245841,0.0001835817,0.0001224042,0.00005476113,0.00004891987,0.0002337323,0.00008066261,0.001636254],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03562779,"threshold_uncertainty_score":0.9999698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404053084","doi":"10.1136/jitc-2024-sitc2024.0716","title":"716 A randomized phase II window of opportunity clinical trial of PD-1 +/- IL-4 inhibition in early-stage ER+ HER2- breast cancer","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Breast cancer; Stage (stratigraphy); Oncology; Window of opportunity; Window (computing); Internal medicine; Medicine; Cancer; Computer science; Biology; Real-time computing","authors":[{"name":"Angel Arnaout","is_ca":false},{"name":"Megan Hopkins","is_ca":true},{"name":"Oleg Saldaña","is_ca":true},{"name":"Vanessa Lopez Ozuna","is_ca":true},{"name":"Vida Talebian","is_ca":true},{"name":"Drashti Jain","is_ca":true},{"name":"Gregory R. Pond","is_ca":true},{"name":"Teresa Petrocelli","is_ca":true},{"name":"Melanie Spears","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04585014480770896,"gpt":0.3498682161185697,"spread":0.3040180713108608,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002555678,0.0002375846,0.001067976,0.0002207605,0.00004759421,0.00002760606,0.00005716856,0.0002682732,0.0001040357],"category_scores_gemma":[0.0004416378,0.0001897394,0.0004234743,0.0003058993,0.0009570604,0.0001818877,0.00003677131,0.0003720216,0.000001202308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007476315,"about_ca_system_score_gemma":0.001190333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002366921,"about_ca_topic_score_gemma":0.0001190096,"domain_scores_codex":[0.9973335,0.0002510322,0.001389997,0.0003752043,0.000400484,0.0002497341],"domain_scores_gemma":[0.9986476,0.0001887661,0.0003462858,0.0002824723,0.0001042605,0.0004305657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8835472,0.001977242,0.003381026,0.001587175,0.001103709,0.000434129,0.001679788,0.00000929029,0.0850994,0.0003550321,0.00185769,0.01896829],"study_design_scores_gemma":[0.8894608,0.002350997,0.04651478,0.003654589,0.0007042165,0.0001951046,0.0002014492,0.0002909891,0.05127623,0.0004939723,0.004441597,0.0004152613],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937434,0.001552167,0.000009212943,0.002215993,0.0007140277,0.001195698,0.0002868631,0.00004456102,0.0002380819],"genre_scores_gemma":[0.9969174,0.001826043,0.00008972763,0.0002616787,0.0002955113,0.00005677448,0.00005141334,0.00003072842,0.000470728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04313375,"threshold_uncertainty_score":0.7737349,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308398717","doi":"10.1136/jitc-2022-sitc2022.0261","title":"261 Evidence for durable anti-tumor responses by TAC-T cells in preclinical models of solid tumors","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Cancer research; Flow cytometry; T cell; Antigen; Bone marrow; Immune system; Cytotoxic T cell; Biology; Molecular biology; Immunology; In vitro","authors":[{"name":"Heather MacGregor","is_ca":false},{"name":"Duane Moogk","is_ca":true},{"name":"Stacey X. Xu","is_ca":false},{"name":"Joanne A. Hammill","is_ca":true},{"name":"Philbert Ip","is_ca":false},{"name":"Ling Wang","is_ca":false},{"name":"Swati Shetty","is_ca":false},{"name":"Kyle MacDonald","is_ca":false},{"name":"Laura Shaver","is_ca":false},{"name":"Sailaja Pirati","is_ca":false},{"name":"Prabha Lal","is_ca":false},{"name":"Christopher W. Helsen","is_ca":false},{"name":"Jonathan L. Bramson","is_ca":true},{"name":"Sadhak Sengupta","is_ca":false},{"name":"Andreas G. Bader","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09622014376030799,"gpt":0.3660636532016021,"spread":0.2698435094412941,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002464425,0.0002384065,0.0007147031,0.0002265157,0.0001590301,0.00003086294,0.000248128,0.00009985931,0.000147333],"category_scores_gemma":[0.001502453,0.0002354737,0.0001732385,0.0003326839,0.000428441,0.0002316718,0.000150282,0.0005358509,0.000002796519],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001544705,"about_ca_system_score_gemma":0.001020502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003036767,"about_ca_topic_score_gemma":0.00001477549,"domain_scores_codex":[0.9969893,0.0002706023,0.0008448795,0.0005830054,0.0007638278,0.0005483567],"domain_scores_gemma":[0.9977683,0.0007819699,0.0002453344,0.0005161467,0.0001336667,0.0005545891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002035638,0.0003192227,0.00874896,0.0005342829,0.00006853916,0.0001632771,0.0004896127,0.001621832,0.9749479,0.00008341233,0.01067023,0.0003171061],"study_design_scores_gemma":[0.004345729,0.002032791,0.0233903,0.0008994204,0.0001302765,0.0004335407,0.0006831558,0.009260139,0.9429799,0.002491175,0.01281454,0.0005390721],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945053,0.002025544,0.00003128315,0.001634986,0.000171851,0.001221512,0.0002162598,0.00004125645,0.0001519715],"genre_scores_gemma":[0.993507,0.0002996204,0.0006927612,0.0004313602,0.00007636629,0.0001841944,0.00002924933,0.00005812768,0.004721317],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03196803,"threshold_uncertainty_score":0.960234,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042304","doi":"10.1136/jitc-2023-sitc2023.1257","title":"1257 Augmenting post-market surveillance of serious drug-induced adverse events with artificial intelligence (AI)-aggregated case reports: proof-of-concept for PD-1/PD-L1 inhibitors for NSCLC","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Adverse Event Reporting System; Adverse effect; Medicine; Internal medicine","authors":[{"name":"Suad Kabbaha","is_ca":false},{"name":"Sarah Carder Dempsey","is_ca":false},{"name":"Aranka Anema","is_ca":false},{"name":"Sonal Singh","is_ca":false},{"name":"Kristian Thorlund","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06243865175087545,"gpt":0.3720942539833658,"spread":0.3096556022324903,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001510589,0.0003998339,0.0005966345,0.0002403895,0.000418906,0.00001703747,0.0001476489,0.0002901439,0.00002341998],"category_scores_gemma":[0.0007688866,0.0003793573,0.0002216299,0.0005411243,0.0004211494,0.0003586297,0.00006656213,0.0004517331,0.000002641842],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007173842,"about_ca_system_score_gemma":0.0005428387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001214768,"about_ca_topic_score_gemma":0.0001200666,"domain_scores_codex":[0.9971586,0.0001788139,0.001089675,0.0006244236,0.0002720229,0.0006764786],"domain_scores_gemma":[0.9972434,0.0005092259,0.0009247466,0.0003069393,0.0005124306,0.0005032411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006527644,0.001825802,0.03540868,0.004261783,0.003051681,0.006015902,0.009203478,0.03182975,0.8417797,0.0005337605,0.01608716,0.04347466],"study_design_scores_gemma":[0.00130375,0.0003056639,0.001601399,0.0002942792,0.000379543,0.001220874,0.001876114,0.005826808,0.978279,0.0008518256,0.007477964,0.0005827657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944942,0.0001508344,0.0001506628,0.0009542835,0.001466757,0.001972285,0.0005638103,0.000140156,0.0001070396],"genre_scores_gemma":[0.9981943,0.00003169395,0.0003505618,0.0002947884,0.0002557675,0.0002436417,0.0002135401,0.0000617991,0.0003539203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1364993,"threshold_uncertainty_score":0.9998658,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308375764","doi":"10.1136/jitc-2022-sitc2022.0059","title":"59 DetermaIO (IO score) is associated with efficacy of ICI monotherapy in advanced NSCLC patients: a retrospective BC Cancer study","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Internal medicine; Medicine; Cohort; Oncology; Retrospective cohort study; Chemotherapy; Cancer; Combination therapy; PD-L1; Immunotherapy","authors":[{"name":"David J. Saltman","is_ca":false},{"name":"Nicole S. Croteau","is_ca":true},{"name":"Heather Lockyer","is_ca":false},{"name":"Robert S. Seitz","is_ca":false},{"name":"Frank McMahon","is_ca":false},{"name":"Jeremy Spille","is_ca":false},{"name":"Andrea M. Dickey","is_ca":false},{"name":"Jordan Jennings","is_ca":false},{"name":"Matthew G. Varga","is_ca":false},{"name":"Kimberly McGregor","is_ca":false},{"name":"Tyler J. Nielsen","is_ca":false},{"name":"David R. Hout","is_ca":false},{"name":"Brock L. Schweitzer","is_ca":false},{"name":"Douglas A. Ross","is_ca":false},{"name":"David R. Gandara","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01331247988039141,"gpt":0.2563421330334675,"spread":0.2430296531530761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003756883,0.0002766062,0.0005864569,0.0001889445,0.0001553651,0.00002190792,0.0001246113,0.00007742841,0.0000827816],"category_scores_gemma":[0.0001138139,0.0002385805,0.0001009593,0.0005675245,0.000229561,0.000131819,0.00004395828,0.0003531568,5.462539e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005774052,"about_ca_system_score_gemma":0.0004158283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001820858,"about_ca_topic_score_gemma":0.0005619343,"domain_scores_codex":[0.9978923,0.0001186113,0.0005253771,0.0004843517,0.0006442779,0.0003350373],"domain_scores_gemma":[0.9988994,0.00004821502,0.000376072,0.0003320533,0.0001404819,0.000203768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004621529,0.001333211,0.9755773,0.00003832305,0.0005268051,0.00006507057,0.005600662,0.0000797685,0.00917009,0.000004583622,0.0002962001,0.002686453],"study_design_scores_gemma":[0.0173086,0.00252748,0.9713516,0.0003431071,0.0001264156,0.00001107305,0.0008234283,0.00003042572,0.006743569,0.000030685,0.0004316639,0.0002719429],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970393,0.0008200326,0.000001013377,0.0003240594,0.0001811243,0.001363596,0.00007665447,0.00004292203,0.000151356],"genre_scores_gemma":[0.9986551,0.0001193554,0.00004662074,0.0006789641,0.00003016407,0.0001659359,0.00003364853,0.00005012689,0.0002200332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01268707,"threshold_uncertainty_score":0.9729031,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3212553475","doi":"10.1136/jitc-2021-sitc2021.466","title":"466 Use of a 27-gene immuno-oncology (IO) assay to associate response to single-agent immune checkpoint inhibitor (ICI) therapy in advanced-stage NSCLC patients from a large Canadian cohort","year":2021,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia","funders":"","keywords":"Oncology; Medicine; Internal medicine; Lung cancer; Cancer; Targeted therapy; Biomarker; Breast cancer; Immunotherapy; Immunohistochemistry; Biology","authors":[{"name":"David L. Saltman","is_ca":false},{"name":"Nicole S. Croteau","is_ca":true},{"name":"Heather Lockyer","is_ca":false},{"name":"Rob Seitz","is_ca":false},{"name":"Frank B. McMahon","is_ca":false},{"name":"Jeremy Spille","is_ca":false},{"name":"Andrea M. Dickey","is_ca":false},{"name":"Matthew G. Varga","is_ca":false},{"name":"Kim McGregor","is_ca":false},{"name":"Tyler J. Nielsen","is_ca":false},{"name":"David R. Hout","is_ca":false},{"name":"Brock L. Schweitzer","is_ca":false},{"name":"Douglas S. Ross","is_ca":false},{"name":"David R. Gandara","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02346754772782018,"gpt":0.2608376512464363,"spread":0.2373701035186161,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001486518,0.0003986256,0.0008898901,0.0003790064,0.0001221099,0.00007288613,0.0001541894,0.0003567428,0.00008010992],"category_scores_gemma":[0.00175476,0.0003946828,0.0002268255,0.0006351198,0.0001547766,0.0001875513,0.00009242788,0.000316645,0.00001330771],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001507959,"about_ca_system_score_gemma":0.002149456,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.04383892,"about_ca_topic_score_gemma":0.03905167,"domain_scores_codex":[0.9965048,0.0004358061,0.00108501,0.0006869292,0.0005248106,0.0007625885],"domain_scores_gemma":[0.9973506,0.0002047101,0.0003144469,0.0006658893,0.0003647592,0.001099537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.006072059,0.000558321,0.1199599,0.00003346522,0.0003825294,0.0003714337,0.002666401,0.00003121384,0.865175,0.000003278976,0.0007855837,0.003960821],"study_design_scores_gemma":[0.004434815,0.00080018,0.5732615,0.0004299225,0.00004619399,0.0000146636,0.000326556,0.000007446908,0.3513645,0.00001002785,0.06900817,0.0002960601],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920183,0.00188813,0.000007620456,0.003218171,0.0008448641,0.001247051,0.0006360851,0.00003729755,0.0001024802],"genre_scores_gemma":[0.9932568,0.0003354661,0.001525155,0.00342554,0.00008211556,0.0000744579,0.0003112829,0.00007276627,0.0009164226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5138105,"threshold_uncertainty_score":0.9998505,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388072441","doi":"10.1136/jitc-2023-sitc2023.0866","title":"866 The effect of butyrophilin 1A1 blockade in combination with radiation treatment in colon and Lewis lung carcinoma","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Radioresistance; Cancer research; Lung cancer; Lewis lung carcinoma; Apoptosis; Medicine; CD44; Radiation therapy; Flow cytometry; Pathology; Cell; Biology; Cancer; Internal medicine; Immunology; Metastasis","authors":[{"name":"Steven H. Lin","is_ca":false},{"name":"Stephen Yoo","is_ca":false},{"name":"Nan Li","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008263332487901847,"gpt":0.2419024171837194,"spread":0.2336390846958175,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004348808,0.0001370879,0.0002585005,0.0001649749,0.00004536464,0.00001628914,0.00003072149,0.00008453891,0.000001797001],"category_scores_gemma":[0.00006398922,0.00008633416,0.00003174878,0.0003350308,0.000185732,0.00006048489,0.000009543215,0.0000909994,5.86158e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001378593,"about_ca_system_score_gemma":0.0001105458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001372532,"about_ca_topic_score_gemma":0.0003230039,"domain_scores_codex":[0.9991619,0.00008814318,0.0002359772,0.0001889734,0.0001640167,0.000161016],"domain_scores_gemma":[0.999561,0.0001061743,0.00008998511,0.0001400896,0.00001615833,0.00008663426],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001155719,0.00005746146,0.9269652,0.0002549283,0.00007733093,0.00008771526,0.001541498,0.00006991797,0.05940775,0.00002274703,0.0001085319,0.01025121],"study_design_scores_gemma":[0.005609411,0.001233246,0.8881684,0.0001845215,0.00006899711,0.00004862111,0.0001142725,0.0007685015,0.1034183,0.00003138663,0.0002721644,0.00008211735],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956271,0.001585007,4.454543e-7,0.001917366,0.0000592325,0.0007363587,0.000006333957,0.00001978969,0.00004836879],"genre_scores_gemma":[0.9993213,0.0003803563,0.00001231948,0.00004307081,0.00002548252,0.00005119009,0.00003389978,0.00001346855,0.0001188999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04401059,"threshold_uncertainty_score":0.3520605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388042588","doi":"10.1136/jitc-2023-sitc2023.0347","title":"347 Functional characterization of GUCY2C-TAC T cells for the treatment of colorectal cancer using preclinical models","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"In vivo; Cancer research; Receptor; In vitro; Antigen; Cancer; Cancer cell; Colorectal cancer; Cytotoxic T cell; Chemistry; Cell biology; Biology; Medicine; Immunology; Internal medicine; Biochemistry","authors":[{"name":"Tania Benatar","is_ca":false},{"name":"Thanyashanthi Nitya-Nootan","is_ca":false},{"name":"Suzanna L. Prosser","is_ca":false},{"name":"Philbert Ip","is_ca":false},{"name":"Prabha Lal","is_ca":false},{"name":"Alima Naim Khan","is_ca":false},{"name":"Stacey X. Xu","is_ca":false},{"name":"Sailaja Pirati","is_ca":false},{"name":"Christopher W. Helsen","is_ca":false},{"name":"Andreas G. Bader","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1143137484958757,"gpt":0.3484156745680693,"spread":0.2341019260721936,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003350622,0.0001377255,0.000334264,0.00009038026,0.00008552206,0.00001458445,0.00005297464,0.0001211059,0.00006075223],"category_scores_gemma":[0.00007003504,0.00009701987,0.0001528026,0.0002079137,0.0002933037,0.00007836289,0.00001707701,0.00007767092,0.000001627968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008845518,"about_ca_system_score_gemma":0.0004370269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001783255,"about_ca_topic_score_gemma":0.00001664465,"domain_scores_codex":[0.9987776,0.00003717745,0.0003913843,0.0002315097,0.0003426293,0.0002196458],"domain_scores_gemma":[0.9990538,0.0002158786,0.0001643401,0.0001871526,0.0001847454,0.0001941058],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005538503,0.0001407011,0.004447642,0.0001586815,0.0002476713,0.000003382678,0.0004690922,0.002200792,0.9887898,0.00006892723,0.0001457579,0.00277368],"study_design_scores_gemma":[0.001955773,0.0006367152,0.1205594,0.0001336158,0.0002776565,0.00001753297,0.00008287376,0.06494081,0.8080747,0.0002953559,0.002905633,0.0001199549],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975556,0.0002733817,0.0001481812,0.0005703707,0.0003453155,0.000896912,0.0001391188,0.00002747577,0.00004371399],"genre_scores_gemma":[0.996488,0.001282164,0.0002521309,0.00004279669,0.000261602,0.00009274558,0.0001143469,0.00003240241,0.00143386],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1807152,"threshold_uncertainty_score":0.3956355,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404052762","doi":"10.1136/jitc-2024-sitc2024.1011","title":"1011 Metabolic reprogramming alters natural killer cell responses in chronic graft-versus-host disease","year":2024,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Reprogramming; Disease; Host (biology); Graft-versus-host disease; Cell; Biology; Immunology; Medicine; Ecology; Genetics; Internal medicine","authors":[{"name":"Ao Mei","is_ca":false},{"name":"Madeline Lauener","is_ca":true},{"name":"Kirk R. Schultz","is_ca":true},{"name":"Subramaniam Malarkannan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01370699216750275,"gpt":0.2467111888803851,"spread":0.2330041967128824,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000403167,0.0003011691,0.00028736,0.00031611,0.0001822481,0.0001426899,0.0001331338,0.0002011691,0.0001543033],"category_scores_gemma":[0.0002803872,0.000271488,0.0001618561,0.0002536346,0.0003269945,0.0004275205,0.00006634129,0.0006585311,0.0004064612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001607914,"about_ca_system_score_gemma":0.0003741139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002850288,"about_ca_topic_score_gemma":0.00005999049,"domain_scores_codex":[0.9981959,0.00020915,0.0004395013,0.0005907599,0.00007938647,0.0004852808],"domain_scores_gemma":[0.9992402,0.0001424496,0.00009100707,0.0003370386,0.00003617066,0.0001531222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001922993,0.0001491674,0.002731956,0.0004110046,0.0003924393,0.0003139366,0.00128916,0.00006942595,0.9600558,0.002167382,0.02549733,0.004999396],"study_design_scores_gemma":[0.001896186,0.0001783518,0.05371093,0.0003489181,0.0001894996,0.000121588,0.0003767004,0.000164319,0.1448575,0.0001001037,0.7975083,0.000547644],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9103154,0.0740673,0.000007852928,0.001008377,0.01359158,0.00028102,0.000005687923,0.0002299464,0.0004928554],"genre_scores_gemma":[0.9794302,0.0008889678,0.00004283138,0.0001904181,0.0001270284,0.00003682843,0.0001328841,0.00004037506,0.01911048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8151983,"threshold_uncertainty_score":0.9999737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388048268","doi":"10.1136/jitc-2023-sitc2023.0838","title":"838 Oncolytic virus induced tumour-infiltrating lymphocytes (TILs) for the treatment of colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Ottawa Hospital; Agricultural Research Institute of Ontario; University of Ottawa","funders":"","keywords":"Oncolytic virus; Tumor-infiltrating lymphocytes; Medicine; Adoptive cell transfer; Colorectal cancer; Tumor microenvironment; Cancer research; Immunotherapy; Cancer; Immune system; Immunology; T cell; Internal medicine","authors":[{"name":"Sydney Vallati","is_ca":true},{"name":"Mathieu J. F. Crupi","is_ca":true},{"name":"Zaid Taha","is_ca":true},{"name":"Julia Petryk","is_ca":true},{"name":"Bradley Austin","is_ca":true},{"name":"Victoria H. Gilchrist","is_ca":true},{"name":"Nouf Alluqmani","is_ca":true},{"name":"Stephen Boulton","is_ca":true},{"name":"John C. Bell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03767717695858579,"gpt":0.3190140528143015,"spread":0.2813368758557157,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003387125,0.0002173351,0.0002367406,0.00006187418,0.0002114009,0.00004598457,0.0001778194,0.0001492854,0.000006446467],"category_scores_gemma":[0.000187659,0.0001605829,0.000136691,0.0001809197,0.0002379546,0.000007284218,0.00003566592,0.00006078856,0.000004892309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007719907,"about_ca_system_score_gemma":0.0006560061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004033587,"about_ca_topic_score_gemma":0.0008637853,"domain_scores_codex":[0.998696,0.00005792149,0.0002893466,0.0003508437,0.0002184049,0.0003875174],"domain_scores_gemma":[0.9991718,0.0001036627,0.0001311516,0.0002656433,0.0001038434,0.0002239026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005094096,0.00005557248,0.001235085,0.00004072495,0.0001932386,0.000004918972,0.0002843917,0.0004673331,0.9913951,0.0000131409,0.000648031,0.005153017],"study_design_scores_gemma":[0.001122954,0.002513776,0.009577245,0.00003063248,0.00005591357,0.00001196101,0.0001761995,0.0008812154,0.9813774,0.00007673672,0.003995898,0.0001800198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961578,0.002375852,0.000005192428,0.0004343986,0.0001972887,0.0006487463,0.00009795947,0.00002890306,0.00005380596],"genre_scores_gemma":[0.9967745,0.002096815,0.00009190175,0.00009862216,0.0002719543,0.000293961,0.00007005607,0.00004255808,0.0002596355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01001769,"threshold_uncertainty_score":0.6548383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3105826467","doi":"10.1136/jitc-2020-sitc2020.0075","title":"75 Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer","year":2020,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Generalizability theory; Blockade; CTLA-4; Cancer; Cancer therapy; Medicine; Oncology; Internal medicine; Immunology; Immune system; Mathematics; T cell; Receptor; Statistics","authors":[{"name":"Dante S. Bortone","is_ca":false},{"name":"Steven Vensko","is_ca":false},{"name":"Sarah Entwistle","is_ca":false},{"name":"Alexandria P. Cogdill","is_ca":false},{"name":"Anne Monette","is_ca":true},{"name":"Yana G. Najjar","is_ca":false},{"name":"Randy F. Sweis","is_ca":false},{"name":"Nicholas Tschernia","is_ca":false},{"name":"Erik Wennerberg","is_ca":false},{"name":"Praveen K. Bommareddy","is_ca":false},{"name":"Cara Haymaker","is_ca":false},{"name":"Uqba Khan","is_ca":false},{"name":"Heather M. McGee","is_ca":false},{"name":"Wungki Park","is_ca":false},{"name":"Houssein Abdul Sater","is_ca":false},{"name":"Christine N. Spencer","is_ca":false},{"name":"Maria Libera Ascierto","is_ca":false},{"name":"Valentin Barsan","is_ca":false},{"name":"Vinita Popat","is_ca":false},{"name":"Sara Valpione","is_ca":false},{"name":"Danny Wells","is_ca":false},{"name":"Vésteinn Thórsson","is_ca":false},{"name":"Roberta Zappasodi","is_ca":false},{"name":"Nils-Petter Rudqvist","is_ca":false},{"name":"Benjamin G. Vincent","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02573454979681641,"gpt":0.2777691241262219,"spread":0.2520345743294055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005740383,0.0001843963,0.0004386337,0.0001201715,0.00003125712,0.00001256891,0.00007758241,0.0001306424,0.0000285717],"category_scores_gemma":[0.000224571,0.0001597416,0.00009016188,0.0003297143,0.0004009737,0.00006409256,0.00003383811,0.000110274,4.225244e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004612865,"about_ca_system_score_gemma":0.0002878296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001561173,"about_ca_topic_score_gemma":0.00003095337,"domain_scores_codex":[0.9985499,0.0001208873,0.0005088777,0.0003425422,0.0002643658,0.0002133757],"domain_scores_gemma":[0.9990795,0.00004025438,0.0001461266,0.0002146332,0.0000763081,0.0004431521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.009455079,0.00007216544,0.07719027,0.0001963701,0.0001650411,0.00002395188,0.00137999,0.00003801574,0.9075911,0.000003882917,0.0006655342,0.003218595],"study_design_scores_gemma":[0.002742464,0.0005779046,0.6028036,0.0001516138,0.00003925309,0.00002309614,0.0001304463,0.00008593677,0.391337,0.00003147732,0.001941409,0.0001357367],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985819,0.003894872,0.000007231756,0.009625307,0.0001016136,0.0004567894,0.00004618939,0.00001834742,0.00003069542],"genre_scores_gemma":[0.9970052,0.0009549151,0.0005616233,0.001344785,0.00006049417,0.00001521977,0.000005782151,0.00002073901,0.00003128562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5256134,"threshold_uncertainty_score":0.6514074,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4308400766","doi":"10.1136/jitc-2022-sitc2022.0913","title":"913 Translational analysis of advanced metastatic bladder cancer patients treated with IO combination maveropepimut-S, cyclophosphamide, and pembrolizumab","year":2022,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"ELISPOT; Immune system; Medicine; Immunotherapy; Immunology; Antigen; T cell; Cancer research; Pembrolizumab","authors":[{"name":"Heather Torrey","is_ca":false},{"name":"Walead Ebrahimizadeh","is_ca":false},{"name":"Valarmathy Kaliaperumal","is_ca":false},{"name":"Aurelio Lobo","is_ca":false},{"name":"Barry E. Kennedy","is_ca":false},{"name":"Tran B. Ngo","is_ca":false},{"name":"Lisa D. MacDonald","is_ca":false},{"name":"Stephan Fiset","is_ca":false},{"name":"Jeremy R. Graff","is_ca":false},{"name":"Heather A. Hirsch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009540570406654516,"gpt":0.2399653680186305,"spread":0.230424797611976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001692229,0.0001885286,0.0004330204,0.0002535303,0.0001651782,0.000018458,0.00004993663,0.00003792536,0.0001195234],"category_scores_gemma":[0.00002257511,0.0001588474,0.00009524687,0.0006756874,0.0002384255,0.0001284738,0.00001740387,0.0001318043,2.130219e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008334593,"about_ca_system_score_gemma":0.0002024909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005189214,"about_ca_topic_score_gemma":0.00008926364,"domain_scores_codex":[0.9985822,0.00006288636,0.000377417,0.0003074876,0.0004879998,0.0001819805],"domain_scores_gemma":[0.9992506,0.00003761465,0.0002331496,0.0001568802,0.0001288878,0.000192874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004810883,0.000652913,0.957495,0.000273836,0.006938495,0.00004232787,0.001574786,0.00274777,0.01682841,0.0001753175,0.0004555883,0.008004683],"study_design_scores_gemma":[0.006413552,0.0005951576,0.9840233,0.00005839419,0.002329521,0.00002261916,0.0001672557,0.0006817311,0.004455858,0.00006158724,0.0009945997,0.0001963852],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967455,0.001950062,0.000006695793,0.0004512111,0.00005844179,0.000418585,0.0001988447,0.00002477571,0.0001458811],"genre_scores_gemma":[0.9984182,0.0003006278,0.0002353119,0.0002485231,0.000008342851,0.00006423456,0.0003908206,0.00002288673,0.0003110213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02652835,"threshold_uncertainty_score":0.6477609,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}